SlideShare a Scribd company logo
1 of 12
Download to read offline
J Pediatr (Rio J). 2014;90(4):344---355
www.jped.com.br
REVIEW ARTICLE
Evaluation of the medication process in pediatric
patients: a meta-analysisଝ
Despina Koumpagiotia,∗
, Christos Varounisb
, Eleni Kletsioub
,
Charalampia Ntelia
, Vasiliki Matziouc
a
P & A Kyriakoy General Children’s Hospital, Athens, Greece
b
Attikon Hospital, Athens, Greece
c
Faculty of Nursing, National and Kapodistrian University, Athens, Greece
Received 16 January 2014; accepted 28 January 2014
Available online 13 April 2014
KEYWORDS
Medication errors;
Children;
Drug errors;
Pediatric patients;
Medication process;
Meta-analysis
Abstract
Objective: to meta-analyze studies that have assessed the medication errors rate in pediatric
patients during prescribing, dispensing, and drug administration.
Sources: searches were performed in the PubMed, Cochrane Library, and Trip databases, select-
ing articles published in English from 2001 to 2010.
Summary of the findings: a total of 25 original studies that met inclusion criteria were selected,
which referred to pediatric inpatients or pediatric patients in emergency departments aged 0-16
years, and assessed the frequency of medication errors in the stages of prescribing, dispensing,
and drug administration.
Conclusions: the combined medication error rate for prescribing errors to medication orders
was 0.175 (95% Confidence Interval: [CI] 0.108-0.270), the rate of prescribing errors to total
medication errors was 0.342 (95% CI: 0.146-0.611), that of dispensing errors to total medication
errors was 0.065 (95% CI: 0.026-0.154), and that ofadministration errors to total medication
errors was 0.316 (95% CI: 0.148-0.550). Furthermore, the combined medication error rate for
administration errors to drug administrations was 0.209 (95% CI: 0.152-0.281). Medication errors
constitute a reality in healthcare services. The medication process is significantly prone to
errors, especially during prescription and drug administration. Implementation of medication
error reduction strategies is required in order to increase the safety and quality of pediatric
healthcare.
© 2014 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
ଝ Please cite this article as: Koumpagioti D, Varounis C, Kletsiou E, Nteli C, Matziou V. Evaluation of the medication process in pediatric
patients: a meta-analysis. J Pediatr (Rio J). 2014;90:344---55.
∗ Corresponding author.
E-mail: dkoumpagioti@nurs.uoa.gr (D. Koumpagioti).
http://dx.doi.org/10.1016/j.jped.2014.01.008
0021-7557/© 2014 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Evaluation of the medication process in pediatric patients 345
PALAVRAS-CHAVE
Erros de medicac¸ão;
Crianc¸as;
Erros de
medicamentos;
Pacientes
pediátricos;
Processo de
medicac¸ão;
Meta-análise
Avaliac¸ão do processo de medicac¸ão em pacientes pediátricos: meta-análise
Resumo
Objetivo: analisar estudos de meta-análise que avaliaram o índice de erros de medicac¸ão em
pacientes pediátricos na prescric¸ão, liberac¸ão e administrac¸ão de medicamentos.
Fontes dos dados: foram feitas buscas nas bases de dados Pubmed, Biblioteca Cochrane e Trip,
selecionando artigos publicados em inglês de 2001 a 2010.
Síntese dos dados: um total de 25 estudos originais que atenderam aos critérios de inclusão foi
selecionado e está relacionado a pacientes pediátricos internados ou pacientes pediátricos nos
Servic¸os de Emergência, com idades entre 0-16 anos. Esses estudos avaliaram a frequência de
erros de medicac¸ão nas etapas de prescric¸ão, liberac¸ão e administrac¸ão de medicamentos.
Conclusões: o índice combinado de erros de medicac¸ão para erros na prescric¸ão/solicitac¸ão de
medicac¸ão foi igual a 0,175 (com intervalos de confianc¸a (IC) de 95%: 0,108-0,270); para erros
na prescric¸ão/total de erros de medicac¸ão foi 0,342, com IC de 95%: 0,146-0,611; para erros na
liberac¸ão/total de erros de medicac¸ão foi 0,065, com IC de 95%: 0,026-0,154; e para erros na
administrac¸ão/total de erros de medicac¸ão foi 0,316, com IC de 95%: 0,148-0,550. Adicional-
mente, o índice combinado de erros de medicac¸ão para erros na administrac¸ão/administrac¸ão
de medicamentos foi igual a 0,209, com IC de 95%: 0,152-0,281. Erros de medicac¸ão con-
stituem uma realidade nos servic¸o de saúde. O processo de medicac¸ão é significativamente
propenso a erros, principalmente na prescric¸ão e administrac¸ão de medicamentos. Precisa
haver a implementac¸ão de estratégias de reduc¸ão dos erros de medicac¸ão para aumentar a
seguranc¸a e a qualidade na prestac¸ão de cuidados de saúde pediátrica.
© 2014 Sociedade Brasileira de Pediatria. Publicado por Elsevier Editora Ltda. Todos os direitos
reservados.
Introduction
Medication errors constitute a reality in healthcare systems,
and are considered to be the most common type of medical
errors, according to the Joint Commission.1
The pediatric
population is under the risk of medication errors due to the
wide variation in body mass, which requires unique drug
doses to be calculated, based on the patient’s weight or
body surface, age, and clinical condition.2
Particularly, med-
ication errors with the potential to cause harm are three
times more likely in pediatric inpatients than in adults.3
The
great majority of medication errors in children pertain to the
stages of prescription and drug administration, according
the results of systematic reviews and original studies.3---6
Consequently, according to the National Coordinating
Council for Medication Error Reporting and Prevention, the
aim of each healthcare organization should be the con-
stant improvement of its systems in order to prevent harm
caused by medication errors.7
Thus, the development of
medication error reduction strategies is an important part
of ensuring the safety and quality of patient care in pedi-
atric population.8
The aim of this study was to meta-analyze
studies that have evaluated the frequency of pediatric
medication errors during prescribing, dispensing, and drug
administration, in order to highlight the vulnerability to
errors of each step, and to improve medication process,
leading to error reduction.
Methods
Definitions terms
For the needs of this meta-analysis, some basic defini-
tions related to the medication errors were used, with the
approval of the review of the institution. The definition
of medication process includes prescribing, transcribing or
documenting, dispensing, administering, and monitoring the
patient.9
Medication error is considered as every error dur-
ing the medication use process.10
Prescribing errors include
incomplete, incorrect, inappropriate request at the time of
physician order, illegibility and/or need for further interpre-
tation, or any missing route, interval, concentration, rate,
dose, and patient data (such as weight, age, or allergies).11
Dispensing error is assumed as any deviation or error deriv-
ing from the receipt of the prescription in the pharmacy to
the supply of a dispensed medicine to the patient.12
Finally,
administration error is defined as any discrepancy occur-
ring between the drug received by the patient and the drug
therapy intended by the physician.12
Literature review
A systematic literature review was conducted from January
of 2001 to December of 2010 using the PubMed, Cochrane,
and Trip databases, using the key words ‘‘medication
errors’’, ‘‘children’’, ‘‘drug errors’’, ‘‘pediatric patients’’,
‘‘medication process’’, and ‘‘meta-analysis’’. The litera-
ture search was based on original studies that met the
inclusion criteria quoted below:
• Studies published in English from January 1, 2001 to
December 31, 2010.
• Studies that referred to pediatric inpatients or pediatric
patients in emergency departments.
• Studies that included patients aged 0 to 16 years.
• Studies that assessed the frequency of medication errors
in the stages of prescribing, dispensing, and drug admin-
istration.
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
346 Koumpagioti D et al.
• Studies that had the same numerators and denominators
for the data grouping.
The exclusion criteria involved studies with incomplete
data whose clarification was not feasible, despite the
researchers’ assistance for the retrieval of required infor-
mation. Furthermore, the exclusion criteria involved studies
that exclusively referred to:
• pediatric outpatients;
• specific drug categories, such as cardiological and anti-
neoplastics, among others;
• specific patient categories, such as oncology; and
• adverse drug events (ADEs).
The studies used for this meta-analysis contained clear
and unambiguous data related to pediatric medication
errors, in these three stages of the process of medica-
tion, and described the frequency of medication errors in
each stage. The majority of these studies were systematic
reviews, and their quality was assessed through the use of
two scales. Due to the absence of a universal scale for the
quality assessment of observational studies (that constitute
the majority of the studies involved in this meta-analysis),
and following the recommendations of the meta-analysis of
observational studies in epidemiology guidelines,13
the qual-
ity of key design components was assessed separately, and
then used to generate a single aggregate score.14
For the
measurement of cohort studies quality, a scale of four ques-
tions (such as cohort inclusion criteria, exposure definition,
clinical outcomes, and adjustment for confounding varia-
bles) was used, while each question was scored on a scale
of 0 to 2, with a maximum quality score of 8, representing
the highest quality score.14
The quality of the one randomized clinical control trial
was assessed by a modified Jadad scale with a maximum
of 3 points. A maximum of 2 points were earned for the
randomization method, and a maximum of 1 point for the
description of withdrawals and dropouts.15
Two independent reviewers screened the title and the
abstract of each study for their correspondence to the
inclusion criteria. In full text articles, two reviewers
decided their eligibility, while the relevant information was
extracted sequentially, so that the second reviewer was able
to study the first reviewer’s extracted information.
Statistical Analysis
For each study, the following error rates were computed
from the reported data: prescribing errors to medication
orders, prescribing errors to total medication errors, dis-
pensing errors to total medication errors, administration
errors to total medication errors, and administration errors
to drug administrations. For each error rate, the pooled
estimates and 95% confidence intervals (95% CIs) were cal-
culated using the random effects model, due to evidence of
significant heterogeneity. Heterogeneity was investigated by
use of I2
statistic. Publication bias was tested statistically
with Egger’s test, which estimates the publication bias by
linear regression approach. Analyses were performed using
the Comprehensive Meta-Analysis software (Comprehensive
Meta-Analysis Software) (CMA) (Biostat, Inc.). CMA uses
computational algorithms to weight studies by inverse vari-
ance. Statistical significance was set at a p-value level of
0.05.
Results
Literature search
Through the systematic literature review, 921 original stud-
ies and systematic reviews were identified, while 775 of
those were excluded due to the absence of subject rele-
vance, and 57 because they were systematic reviews. 89
studies remained and were evaluated further, while 20 of
those were rejected due to the existence of the same stud-
ies in different databases. Finally, from the remaining 69
studies, 44 were excluded because they didn’t meet the
inclusion criteria. Consequently, 25 original studies were
included in this meta-analysis. Fig. 1 represents the flow
diagram and provides an overview of the literature review
and studies’ selection.
Characteristics of the studies
Table 1 shows the basic characteristics of the 25
studies included in the meta-analysis. In a total of
25 studies, there were nine cohort studies,3,5,11,16---21
three retrospective cohort studies,22---24
seven retrospec-
tive studies,4,25---30
two interventional studies,31,32
one
quasi-experimental study,33
one cross-sectional study,34
one randomized controlled trial,35
and one observa-
tional study.36
Furthermore, the majority of the studies
relied on chart review for the data collection (17 of
25),3,5,11,18,20---22,24,26---32,34,35
while four of the 25 studies relied
on error reporting systems,4,17,18,23,25
three of 25 studies
on observation,16,19,36
and one study on chart review and
interviews.33
Regarding the types of medication errors iden-
tified through these studies, nine of 25 reported prescribing
errors;11,24,26,28,30---33,35
three of 25 studies, administration
errors;16,19,36
five of 25 studies, prescribing and administra-
tion errors;21,22,29,34
seven studies, all types of medication
errors;3---5,17,18,23,25
and one study reported prescribing and
dispensing errors.27
Finally, 17 studies referred to pediatric
inpatients,3---5,11,16---21,23,25,28,31---32,34,36
seven studies to pedi-
atric patients in emergency departments,22,24,26,29,30,33,35
and
one study to pediatric inpatients and patients in emergency
departments.27
In studies in which there was
intervention,5,11,17---18,21,23---24,28,29,31---36
data was obtained
from phase I only, as presented in Table 1.
Therefore, great heterogeneity between the studies was
observed, due to the difference in parameters and condi-
tions used for the data collection. Significant heterogeneity
was observed in the manner that medication errors and their
categories were defined by each study. Namely, there were
studies in which administration errors included every error
from the stage of drug dispensing in the ward by the nursing
staff to drug administration, such as those by Chua et al.,19
Fontan et al.,21
and Jain et al.27
These studies, in this meta-
analysis, were classified in the category of administration
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Evaluationofthemedicationprocessinpediatricpatients347
Table 1 Characteristics of the studies included in the meta-analysis.
Studies Study
Design
Setting Duration Instruments
used for the
data
collection
Error types Results Quality
Cowley et al.,4
2001
USA
Retrospective Pediatric
Inpatients
01/1999
---12/2000
Error
reporting
system
All types 143 prescribing errors,
449 dispensing errors,
1007 administration errors,
in a total of 1,956
medication errors
-
Kaushal et al.,3
2001
USA
Cohort PICU,
Medical/surgical
wards,
short-stay
medical ward
04/1999
---05/1999
Chart
review
All types 454 prescribing errors,
6 dispensing errors, 78
administration errors, in a
total of 616 medication
errors
7
Sangtawesin
et al.,25
2003
Thailand
Retrospective PICU, NICU 09/2001
---11/2002
Error
reporting
system
All types 114 prescribing errors,
112 dispensing errors, 49
administration errors, in a
total of 322 medication
errors
-
Kozer et al.,22
2002
Canada
Retrospective
cohort
Emergency
department
12 randomly
days of 2000
Chart
review
Prescribing,
administration
271 prescribing errors
per 1,678 medication
orders, 59 administration
errors per 1,532 charts
7
Cimino et al.,31
2004
USA
Interventional PICU 2 weeks Chart
review
Prescribing 3,259 errors per 12,026
medication orders
-
Potts et al.,11
2004
USA
Cohort PICU 10/2001
---12/2001
(1st
phase)
Chart
review
Prescribing 2,049 errors per 6,803
medication orders
6
Prot et al.,16
2005
France
Cohort PICU, NICU,
general
pediatric,
and
nephrological
unit
04/2002
---03/2003
Observation Administration 538 errors per 1,719
drug administrations
7
Frey et al.,17
2002
Switzerland
Cohort PICU 01/01/2000
---31/12/2000
Error
reporting
system
All types 102 prescribing errors,
162 dispensing errors, 200
administration errors in a
total of 275 medication
errors
7
348KoumpagiotiDetal.
Table 1 (Continued )
Studies Study
Design
Setting Duration Instruments
used for the
data
collection
Error types Results Quality
Porter et al.,33
2008
USA
Quasi-
experimental
Emergency
department
06/2005
---06/2006
Chart
review,
interviews
Prescribing 1,755 errors per 2,234
medication orders
-
Taylor et al.,26
2005
USA
Retrospective Emergency
department
01/1998
-06/1998
Chart
review
Prescribing 311 errors per 358
medication orders
-
Wang et al.,18
2007
USA
Cohort PICU, NICU,
pediatric ward
02/2002
---04/2002
Chart
review,
error
reporting
system
All types 464 prescribing errors,
2 dispensing errors, 101
administration errors in a
total of 865 medication
errors
6
King et al.,23
2003
Canada
Retrospective
cohort
Medical and
surgical
ward
04/1993
---03/1996
(1st
phase)
Error
reporting
system
All types 13 prescribing errors,
19 dispensing errors, 314
administration errors in a
total of 416 medication
errors
7
Kozer et al.,35
2005
Canada
Randomized
control
clinical trial
Emergency
department
07/2001 Chart
review
Prescribing 68 errors per 411
medication orders
3
(Jadad
score)
Otero et al.,34
2008
Argentina
Cross-
sectional
ICU, NICU
pediatrics
clinic
06/2002
(1st
phase)
Chart
review
Prescribing,
administration
102 prescribing errors
per 590 medication orders
99 administration errors per
1,174 drug administrations
-
Fortescue
et al.,5
2003
USA
Cohort PICU, NICU,
short-stay
medical
ward, medical/
surgical ward
04/1999
---05/1999
Chart
review
All types 479 prescribing errors,
6 dispensing errors, 79
administration errors in a
total of 616 medication
errors
5
Chua et al.,19
2010
Malaysia
Cohort Pediatric ward 11/2004
---01/2005
Observation Administration 100 errors per 857
drug administrations
5
Ghaleb et al.,20
2010
UK
Cohort PICU, NICU
medical and
surgical
ward
2004-
2005
for 22
weeks
Chart
review
Prescribing,
administration
391 prescribing errors
per 2,955 medication orders
429 administration errors
per 1,544 drug
administrations
5
Evaluationofthemedicationprocessinpediatricpatients349
Table 1 (Continued )
Studies Study
Design
Setting Duration Instruments
used for the
data
collection
Error types Results Quality
Fontan et al.,21
2003
France
Cohort Nephrological
Unit
02/1999
---03/1999
Chart
review
Prescribing,
administration
937 prescribing errors
per 4,532 medication orders
1077 administration errors
per 4,135 drug
administrations
6
Raja Lope et al.,36
Malaysia
Observational NICU 02/2005
(1st
phase)
Observation Administration 59 errors per 188 drug
administrations
-
Sard et al.,24
2008 USA
Retrospective
cohort
Emergency
department
2005 Chart
review
Prescribing 101 errors per 326
medication orders
7
Jain et al.,27
2009 India
Retrospective PICU,
Emergency
department
01/2004
---04/2004
Chart
review
Prescribing,
dispensing
67 prescribing errors &
14 dispensing errors
per 821 medication orders
-
Kadmon
et al.,28
2009
Israel
Retrospective PICU 09/2001
(1st
phase)
Chart
review
Prescribing 103 errors per 1,250
medication orders
-
Larose et al.,29
2008
Canada
Retrospective Emergency
department
2003
(1st
phase)
Chart
review
Prescribing,
administration
32 prescribing errors &
23 administration errors per
372 medication orders
-
Rinke et al.,30
2008
USA
Retrospective Emergency
department
04/2005
---09/2005
Chart
review
Prescribing 81 errors per 1,073
medication orders
-
Campino
et al.,32
2009
Spain
Interventional NICU 09/2005-
02/2006
Chart
review
Prescribing 868 errors per 4,182
medication orders
-
PICU, pediatric intensive care unit; NICU, neonatal intensive care unit
350 Koumpagioti D et al.
Studies screened for retrieval
• Pubmed: n=862
• Cochrane: n=38
• Trip database: n=21
Total: n=921
n=775 studies excluded for non-relevant
subject
n = 89 studies retrieved for further evaluation
n=69 studies potentially appropriate
n=20 excluded (duplicates)
44 studies excluded for:
• n=11 exclusively referring
to pediatric outpatients
• n=12 for specific drug categories
• n=5 for specific patient categories
• n=10 for adverse drug events
• n=6 due to incomplete data
n=57 studies excluded (systematic reviews)
Ν=25 original studies used
in the meta-analysis while they met
the inclusion criteria
Figure 1 Flow diagram of studies included in the meta-analysis.
errors. In other studies, dispensing errors were defined as
errors during drug dispensing by the pharmacist.5,8,17,18,23,25
Difference was also noticed between the definitions of
prescribing errors across the studies. While the majority of
the studies used the broadest sense of the term ‘‘prescribing
error’’,20,24,26,29,32---34
as the one used for this meta-analysis,
there were studies that used the term prescribing error
solely as any incomplete or ambiguous order.11,28
Moreover, there was a differentiation in the instruments
used for the data collection by each study, the studies’
design, the age groups that took part in each study, the sett-
ings, and the numerators and denominators used by each
study for the assessment of the frequency of medication
error occurrence.
Statistical Results
For the purposes of this study, five groups based on com-
mon numerators and denominators were combined. The
numerator and the denominator of each study constitute
the estimated relative measure. Through the use of the esti-
mated relative measure (numerator/denominator) of each
study, integrated error rates were calculated for each of
these groups. Most studies participated in more than one
group. The first group, specifically, included prescribing
errors in relation to the medication orders. The prescrib-
ing errors were defined as numerators and the medication
orders as denominators. The prescribing error rate per
medication orders was calculated as 0.175 (95% CI: 0.108-
0.270; p-value < 0.001). The second group related to
prescribing errors (numerator) and total medication errors
(denominator). The integrated prescribing error rate was
0.342 (95% CI: 0.146-0.611; p-value = 0.246). The third group
included dispensing errors (numerator) and total medication
errors (denominator). The total dispensing error rate was
estimated as 0.065 (95% CI: 0.026-0.154; p-value < 0.001).
The fourth group consisted of administration errors as
numerator and total medication errors as denominator,
with a total administration error rate of 0.316 (95% CI:
0.148-0.550; p-value = 0.119). Finally, the fifth group con-
tained administration errors per drug administration. The
integrated administration error rate was 0.209, (95% CI:
0.152-0.281; p-value < 0.001).
Prescribing errors per medication orders
Eighteen studies were used for this group. Nine of 18 studies
referred exclusively to prescribing errors;11,26,30---33,35
five of
18, to prescribing and administration errors;20---22,29,34
one of
18, to prescribing and dispensing errors;27
and three of 18, to
all types of errors.3,5,18
Furthermore, all studies comprised
by this group clearly described the number of medication
orders, screened for prescribing errors. On Fig. 2, all 18
studies are represented, as well as the error rates of each
study (from the ratio of prescribing errors per medication
orders of each study) and the random effect rate. In a
total of 78,135 medication orders from these 18 studies,
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Evaluation of the medication process in pediatric patients 351
Error rate: the frequency of
prescription errors per medication
Studies Error rate Lower limit Upper limit Z-score p-value
Jain et al.27 0.082 0.065 0.102 –18.989 0.000
Kadmon et al.28 0.082 0.068 0.099 –23.431 0.000
Ghaleb et al.20 0.132 0.121 0.145 –34.639 0.000
Otero et al.34 0.173 0.144 0.206 –14.378 0.000
Larose et al.29 0.086 0.061 0.119 –12.780 0.000
Porter et al.33 0.786 0.768 0.802 25.189 0.000
Rinke et al.30 0.075 0.061 0.093 –21.680 0.000
Campino et al.32 0.208 0.196 0.220 –35.136 0.000
Sard et al.24 0.310 0.262 0.362 –6.688 0.000
Wang et al.18 0.027 0.025 0.030 –75.832 0.000
Kozer et al.35 0.165 0.133 0.205 –12.190 0.000
Taylor et al.26 0.869 0.830 0.900 12.074 0.000
Cimino et al.31 0.271 0.263 0.279 –48.234 0.000
Potts et al.11 0.391 0.380 0.403 –17.787 0.000
Fortescue et al.5 0.044 0.041 0.048 –65.640 0.000
Fontan et al.21 0.207 0.195 0.219 –36.658 0.000
Kozer et al.22
0.162 0.145 0.180 –24.829 0.000
Kaushal et al.2
0.042 0.038 0.046 –65.150 0.000
0.175 0.108 0.270 –5.461 0.000
–1.00 –0.50 0.00 0.50 1.00
I2 = 99.8%. p < 0.001
Egger’s test: a = –10.58, p = 0.32
Error rate and 95% CI
Figure 2 The estimated relative measures for prescription errors per medication order, with 95% CIs (95% Confidence Intervals),
the integrated error rate, and the forest plot.
the integrated error rate was calculated as 0.175, (95% CI:
0.108-0.270;and p-value < 0.001). In Fig. 2, the forest plot
is illustrated. The vertical axis of the forest plot represents
the studies, while the horizontal axis, the estimated rel-
ative measures. Squares illustrate the estimated relative
measures of each study and the diamond, the integrated
error rate calculated through the random effect model.
No potential publication bias was found by Egger’s test
(intercept a = −0.400;95% CI: -1.594 to 0.792; p = 0.443).
Moreover, the heterogeneity between the studies was
very high, as investigated by the I2
statistic (I2
= 99.8%;
p < 0.001).
Prescribing errors per total medication errors
In this group, seven studies3,4,17,18,23,25
concerning all types
of errors with the inclusion of prescribing errors were
included. Fig. 3 provides an overview of the referred
studies with their error rates. The integrated prescribing
error rate estimated in a total of 5,066 medication errors
from these seven studies was 0.342 (95% CI: 0.146-0.611;
p-value = 0.246).Additionally, in the forest plot, the signif-
icant heterogeneity between the studies is illustrated, as
the estimated relative measures of each study (squares)
are distributed heterogeneously around the integrated error
rate (diamond). No potential publication bias was found by
Egger’s test (intercept a = -12.40; 95% CI: -60.19 to 35.39;
p > 0.05), and very high heterogeneity as I2
> 50% (I2
= 99.5%;
p < 0.001).
Dispensing errors per total medication errors
The same seven studies3,4,17,18,23,25
used for this group
refer to all types of errors, including dispensing errors. An
overview of the studies and the forest plot is showcased
in Fig. 4. The integrated dispensing error rate was 0.065
Studies
Wang et al.18
Fortescue et al.5
Sangtawesin et
al.25
King et al.23
Frey et al.17
Kaushal et al.3
Cowley et al.4
Ι2 = 99.5%. p < 0.001
Egger’s test: a = –12.40, p = 0.53
Error rate
0.536
0.778
0.354
0.031
0.371
0.737
0.073
0.342
Lower
limit
0.503
0.743
0.304
0.018
0.316
0.701
0.062
0.146
Upper
limit
0.569
0.809
0.408
0.053
0.430
0.770
0.086
0.611
Z-score
2.140
12.919
–5.160
–12.186
–4.232
11.260
–29.241
–1.161
Error rate: The frequency of prescription
errors per total medication errors.
p-value
0.032
0.000
0.000
0.000
0.000
0.000
0.000
0.246
–1.00 –0.50 0.00 0.50 1.00
Error rate and 95% CI
Figure 3 The estimated relative measures for prescription errors per total medication errors, with 95% CIs (95% Confidence
Intervals), the integrated error rate, and the forest plot.
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
352 Koumpagioti D et al.
Studies
Wang et al.18
Fortescue et al.5
Sangtawesin et al.25
King et al.23
Frey et al.17
Kaushal et al.3
Cowley et al.4
Ι2 = 98.6%. p < 0.001
Egger’s test: a = –6.59, p = 0.21
Error
rate
0.002
0.010
0.348
0.046
0.589
0.010
0.230
0.065
Lower
limit
0.001
0.004
0.298
0.029
0.530
0.004
0.211
0.026
Upper
limit
0.009
0.022
0.401
0.070
0.646
0.022
0.249
0.154
Z-score
–8.570
–11.266
–5.372
–12.943
2.939
–11.266
–22.521
–5.416
Error rate: The frequency of dispensing
errors per total medicationerrors.
p-value
0.000
0.000
0.000
0.000
0.003
0.000
0.000
0.000
Error rate and 95 % CI
–1.00 –0.50 0.00 0.50 1.00
Figure 4 The estimated relative measures for dispensing errors per total medication errors, with 95% CIs (95% Confidence
Intervals), the integrated error rate, and the forest plot.
(95% CI: 0.026-0.154; p-value < 0.001). Consequently, in a
total of 5,066 medication errors, the random effect rate
was measured to 6.5%.
No potential publication bias was found by Egger’s test
(intercept a = -6.50; 95% CI: -18.17 to 5.15; p = 0.21), and
very high heterogeneity as I2
> 50% (I2
= 98.6%; p < 0.001).
Administration errors per total medication errors
The same seven studies3,4,17,18,23,25
included in this group
reported all types of medication errors, as well as dispens-
ing errors. Fig. 5 shows the estimated relative measures
for each study, and the forest plot presents the distribu-
tion of the studies around the integrated error rate. The
administration error rate was 0.316 (95% CI: 0.148-0.550; p-
value = 0.119). Thus, in a total of 5,066 medication errors,
the random effect rate was 31.6%.
No potential publication bias was found by Egger’s test
(intercept a = -11.70; 95% CI: -39.90 to 16.49; p = 0.33), and
very high heterogeneity as I2
> 50% (I2
= 98.6%, p < 0.001).
Administration errors per drug administrations
Six studies16,19---21,34,36
with common numerators (administra-
tion errors) and denominators (drug administrations) were
chosen for this group. For each study, the estimated rel-
ative measures were calculated, as well as the integrated
administration error rate, which measured 0.209 (95% CI:
0.152-0.281; p-value < 0.001). Fig. 6 provides an overview of
the ratios of administration errors per drug administration
and the forest plot that illustrates the studies’ contribu-
tion to the value of the integrated error rate. In a total
of 9,167 drug administrations, from these six studies, the
random effect error rate was as 20.9%.
No potential publication bias was found by Egger’s test
(intercept a = -8.28; 95% CI: -25.95 to 9.38; p = 0.26), and
very high heterogeneity as I2
> 50% (I2
= 98.2%; p < 0.001).
Discussion
Medication errors cause serious problems in daily clinical
practice and are of significant concern, especially for the
pediatric population. Many of the members of the disci-
plinary team may be involved in the causation of medication
errors, such as clinicians, nurses, pharmacists, although
there is great speculation regarding their management and
reduction. In this meta-analysis, the authors tried to esti-
mate a more integrated result in relation to the frequency
and nature of medication errors in pediatric patients, dur-
ing the stages of prescribing, dispensing, and administration.
For this objective, five different groups were created, after
a careful selection of studies that met the goals of each
group. Therefore, the integrated rate in relation to the pre-
scribing errors per medication order was calculated as0.175,
and in relation to the prescribing errors per total medication
errors, dispensing errors per total medication errors, and
administration errors per total medication errors were cal-
culated as 0.342, 0.065, and 0.316, respectively. Moreover,
the integrated rate for the ratio of administration errors per
drug administration was estimated as 0.209.
This study highlighted the most vulnerable stages in the
medication use process. The highest rates were observed in
prescribing and drug administration, managed by clinicians
and nurses, respectively. Additionally, comparing the results
between the groups, the predominance of prescribing errors
can be discerned, followed by administration errors; dis-
pensing errors had the lowest rates. Due to the absence
of other meta-analyses in relation to medication errors in
children, it’s impossible to compare the results with other
studies. Therefore, because of the occurrence of systematic
reviews, the two stages of medication process (prescribing
and administration) present the highest error rates, as
shown in the study by Miller et al., in which prescribing
errors varied between 3% and 37% and administration errors
between 72% and 75%.6
Moreover, according to the review
of eight studies, which used observation for administration
error identification, Ghaleb et al. highlighted administra-
tion error rates per drug administration of 0.6% to 27%.2
These rates agree with that of the present meta-analysis,
which was calculated as 20.9%. Moreover, Miller et al.
estimated that 5% to 27% of medication orders for children
contained an error throughout the entire medication pro-
cess, involving prescribing, dispensing, and administration,
based on three studies;6
in the current meta-analysis, the
integrated error rate for prescribing errors per medication
order approached 17.5%.
Dispensing errors, conversely, presented the lowest rate
(6.5%), in contrast to the other two stages of the medi-
cation use process. However, in the study by Miller et al.,
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Evaluation of the medication process in pediatric patients 353
C
Studies
Wang et al.18
Fortescue et al.5
Sangtawesin et al.25
King et al.23
Frey et al.17
Kaushal et al.3
Cowley et al.4
Ι2
= 98.6%. p < 0.001
Egger’s test: a = –11.70, p = 0.33
0.117
0.128
0.152
0.755
0.727
0.127
0.515
0.316
Error
rate
Lower
limit
0.097
0.104
0.117
0.711
0.672
0.103
0.493
0.148
Upp er
limit
0.140
0.157
0.196
0.794
0.777
0.155
0.537
0.550
Z-score
–19.111
–15.905
–11.071
9.866
7.244
–15.939
1.311
–1.559
p-value
0.000
0.000
0.000
0.000
0.000
0.000
0.190
0.119 Error rate: The frequency of
administration errors per total
medication errors.
Error rate and 95% CI
–1.00 –0.50 0.00 0.50 1.00
Figure 5 The estimated relative measures for administration errors per total medication errors, with 95% CIs (95% Confidence
Intervals), the integrated error rate, and the forest plot.
Studies
Raja Lope et al.36
Ghaleb et al.2
Otero et al.34
Prot et al.16
Chua et al.19
Fontan et al.21
Ι2 = 98.2%. p < 0.001
Egger’s test: a = –8.28, p = 0.26
Error
rate
0.117
0.314
0.276
0.084 0.070
0.313
0.260
0.209
Lower
limit
0.097
0.254
0.291
0.247
0.152
Upper
limitt
0.140
0.252 0.384
0.299
0.102
0.335
0.274
0.281
Z-score
–19.024
–4.977
–16.990
–22.707
–15.116
–29.452
–6.676
p-value
0.000
0.000
0.000
0.000
0.000
0.000
0.000
Error rate: the frequency of administration
errors per total drug administrations.
–0.50 –0.25 0.00 0.25 0.50
Error rate and 95%% CI
Figure 6 The estimated relative measures for administration errors per drug administrations, with 95% CIs (95% Confidence
Intervals), the integrated error rate, and the forest plot.
the dispensing error rates ranged between 5% and 58%, as
calculated through the use of three studies, due to the het-
erogeneity presented in the others studies.6
The use of I2
statistic showcased significant heterogene-
ity between the studies, as I2
was > 50% in all five groups.
This heterogeneity is reflected in the forest plots of each
group, with the heterogeneous distribution of the studies
around the integrated error rate. Furthermore, Egger’s test
indicated the absence of potential publication bias.
The members of the disciplinary team manage the medi-
cation delivery system and as a result, they become involved
in medication errors of pediatric patients. A medication
error is not the direct result of a sole member of the dis-
ciplinary team’s misconduct, and the accusation of that
person should not be pursued or recognized as a reward
for reporting the error. The awareness of the existence of
medication errors in clinical daily practice, as well as the
interactive nature of the medication use process, with the
participation of all members of the disciplinary team, leads
to a better understanding of the errors. Consequently, the
results of this meta-analysis offer useful information for
healthcare professionals, as they provide the opportunity
of understanding the nature and frequency of medication
errors, and the ability to re-evaluate and improve the med-
ication process.
Furthermore, the existence of integrated error rates,
related to medication errors in pediatric patients, can con-
tribute to the understanding of the nature, frequency, and
consequences of medication errors, as well as the necessity
of the development of medication error reduction strate-
gies, staff education, and clinical protocols and guidelines.
Limitations
The evaluation of the heterogeneity and the identification
of its causes constitute parallel limitations of this meta-
analysis. The selection of the studies solely published in
English was a limitation, as well as the heterogeneity of the
studies.
The heterogeneity emanates from the variety of the stud-
ies’ characteristics. Initially, the different error definition,
as previously mentioned, complicated the studies’ grouping.
Another reason was the different conditions under which
each study took place. Emergency departments, for exam-
ple, represented higher prescribing error rates,22,27,29,33
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
354 Koumpagioti D et al.
while pediatric intensive care units and neonatal intensive
care units presented high rates in all types of medication
errors.11,16---18,25,31,32,34,36
There was also a variation in the studies’ design (cohort,
randomized controlled trial, cross-sectional, retrospective,
interventional), as well as in the age groups that took part
in each study. Some of the age groups, such as neonates,
may be more vulnerable to medication errors than preschool
or school age children, due to their organic prematurity,
the very small amounts of therapeutic drug doses, or their
serious clinical condition.
The denominators that each study used for the deter-
mination of error frequency vary. Certain studies used
handwritten orders or computerized orders as denomina-
tors, while others were based on drug administrations.
Computerized orders are more susceptible to the recog-
nition of prescribing errors, in contrast to handwritten
orders, where the identification of the error is at the dis-
posal of the researcher or the professional who reported
the error. Finally, there was a variety in the instruments
that each study used for the data collection. Some stud-
ies used chart reviews or observation, while others used
error-reporting systems, thus minimizing the possibility of
recognizing more errors, in contrast to using a combination
of those instruments.6
In conclusion, medication errors in pediatric patients
constitute a daily phenomenon in hospitals. Through this
meta-analysis, it has been ascertained that the stages of
prescription and administration were more prone to errors,
as they demonstrated higher rates than the stage of dispens-
ing. The stage of dispensing had the lowest error rates, with
the pharmacist responsible for medication dispensing in the
majority of the studies.
The results of this meta-analysis highlight the neces-
sity to improve the way that both clinicians and nurses are
managing the medication process during the pediatric care
delivering. Furthermore, the communication between the
members of the multidisciplinary team regarding medica-
tion errors in children should be focused on adoption of
common definitions for medication errors and their cate-
gories, staff education in recognizing medication errors, and
implementation of error reporting in daily clinical practice.
The establishment of medication error reduction strate-
gies should constitute a goal for all healthcare institutions
and a stimulus for the improvement of the pediatric care
delivery.
Conflicts of interest
The authors declare no conflicts of interest.
References
1. The Joint Commission. Sentinel event alert: preventing pedi-
atric medication errors. Issue 39, April 11, 2008. [cited 1
Aug 2011]. Available from: http://www.jointcommission.org/
SentinelEvents/SentinelEventAlert/sea 39.htm
2. Ghaleb MA, Barber N, Franklin BD, Yeung VW, Khaki ZF, Wong IC.
Systematic review of medication errors in pediatric patients.
Ann Pharmacother. 2006;40:1766---76.
3. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Fed-
erico F, et al. Medication errors and adverse drug events in
pediatric inpatients. JAMA. 2001;285:2114---20.
4. Cowley E, Williams R, Cousins D. Medication errors in chil-
dren: a descriptive summary of medication error reports
submitted to the United States pharmacopeia. Curr Ther Res.
2001;62:627---40.
5. Fortescue EB, Kaushal R, Landrigan CP, McKenna KJ, Clapp MD,
Federico F, et al. Prioritizing strategies for preventing medi-
cation errors and adverse drug events in pediatric inpatients.
Pediatrics. 2003;111:722---9.
6. Miller MR, Robinson KA, Lubomski LH, Rinke ML, Pronovost
PJ. Medication errors in paediatric care: a systematic review
of epidemiology and an evaluation of evidence supporting
reduction strategy recommendations. Qual Saf Health Care.
2007;16:116---26.
7. National Coordinating Council for Medication Error Repor-
ting and Prevention. Statement from NCC MERP: use of
medication error rates to compare health care organiza-
tions is of no value. [cited 1 Oct 2011]. Available from:
http://www.nccmerp.org/council/council2002-06-11.html
8. Gonzales K. Medication administration errors and the pediatric
population: a systematic search of the literature. J Pediatr Nurs.
2010;25:555---65.
9. United States Pharmacopeia. Medication use process.
Rockville, MD: United States Pharmacopeia; 2004. [cited
1 Aug 2011]. Available from: http://www.usp.org/pdf/EN/
patientSafety/medicationUseProcess.pdf
10. Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, et al.
Outpatient prescribing errors and the impact of computerized
prescribing. J Gen Intern Med. 2005;20:837---41.
11. Potts AL, Barr FE, Gregory DF, Wright L, Patel NR. Computer-
ized physician order entry and medication errors in a pediatric
critical care unit. Pediatrics. 2004;113:59---63.
12. Williams DJ. Medication errors. J R Coll Physicians Edinb.
2007;37:343---6.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD,
Rennie D, et al., Meta-analysis Of Observational Studies in
Epidemiology (MOOSE) group. Meta-analysis of observational
studies in epidemiology: a proposal for reporting. JAMA.
2000;283:2008---12.
14. Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins
in COPD: a systematic review. Chest. 2009;136:734---43.
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ,
Gavaghan DJ, et al. Assessing the quality of reports of ran-
domized clinical trials: is blinding necessary? Control Clin Trials.
1996;17:1---12.
16. Prot S, Fontan JE, Alberti C, Bourdon O, Farnoux C, Macher
MA, et al. Drug administration errors and their determinants
in pediatric in-patients. Int J Qual Health Care. 2005;17:
381---9.
17. Frey B, Buettiker V, Hug MI, Waldvogel K, Gessler P, Ghelfi D,
et al. Does critical incident reporting contribute to medication
error prevention? Eur J Pediatr. 2002;161:594---9.
18. Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten
SR. Prevention of pediatric medication errors by hospital phar-
macists and the potential benefit of computerized physician
order entry. Pediatrics. 2007;119:e77---85.
19. Chua SS, Chua HM, Omar A. Drug administration errors in pae-
diatric wards: a direct observation approach. Eur J Pediatr.
2010;169:603---11.
20. Ghaleb MA, Barber N, Franklin BD, Wong IC. The incidence and
nature of prescribing and medication administration errors in
paediatric inpatients. Arch Dis Child. 2010;95:113---8.
21. Fontan JE, Maneglier V, Nguyen VX, Loirat C, Brion F. Medica-
tion errors in hospitals: computerized unit dose drug dispensing
system versus ward stock distribution system. Pharm World Sci.
2003;25:112---7.
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
Evaluation of the medication process in pediatric patients 355
22. Kozer E, Scolnik D, Macpherson A, Keays T, Shi K, Luk T, et al.
Variables associated with medication errors in pediatric emer-
gency medicine. Pediatrics. 2002;110:737---42.
23. King WJ, Paice N, Rangrej J, Forestell GJ, Swartz R. The effect
of computerized physician order entry on medication errors
and adverse drug events in pediatric inpatients. Pediatrics.
2003;112:506---9.
24. Sard BE, Walsh KE, Doros G, Hannon M, Moschetti W, Bauchner
H. Retrospective evaluation of a computerized physician order
entry adaptation to prevent prescribing errors in a pediatric
emergency department. Pediatrics. 2008;122:782---7.
25. Sangtawesin V, Kanjanapattanakul W, Srisan P, Nawasiri W,
Ingchareonsunthorn P. Medication errors at Queen Sirikit
National Institute of Child Health. J Med Assoc Thai.
2003;86:S570---5.
26. Taylor BL, Selbst SM, Shah AE. Prescription writing errors in
the pediatric emergency department. Pediatr Emerg Care.
2005;21:822---7.
27. Jain S, Basu S, Parmar VR. Medication errors in neonates admit-
ted in intensive care unit and emergency department. Indian J
Med Sci. 2009;63:145---51.
28. Kadmon G, Bron-Harlev E, Nahum E, Schiller O, Haski G,
Shonfeld T. Computerized order entry with limited decision
support to prevent prescription errors in a PICU. Pediatrics.
2009;124:935---40.
29. Larose G, Bailey B, Lebel D. Quality of orders for medication in
the resuscitation room of a pediatric emergency department.
Pediatr Emerg Care. 2008;24:609---14.
30. Rinke ML, Moon M, Clark JS, Mudd S, Miller MR. Prescribing
errors in a pediatric emergency department. Pediatr Emerg
Care. 2008;24:1---8.
31. Cimino MA, Kirschbaum MS, Brodsky L, Shaha SH. Child
Health Accountability Initiative. Assessing medication prescrib-
ing errors in pediatric intensive care units. Pediatr Crit Care
Med. 2004;5:124---32.
32. Campino A, Lopez-Herrera MC, Lopez-de-Heredia I, Valls-i-
Soler A. Educational strategy to reduce medication errors
in a neonatal intensive care unit. Acta Paediatr. 2009;98:
782---5.
33. Porter SC, Kaushal R, Forbes PW, Goldmann D, Kalish LA.
Impact of a patient-centered technology on medication errors
during pediatric emergency care. Ambul Pediatr. 2008;8:
329---35.
34. Otero P, Leyton A, Mariani G, Ceriani Cernadas JM, Patient
Safety Committee. Medication errors in pediatric inpatients:
prevalence and results of a prevention program. Pediatrics.
2008;122:e737---43.
35. Kozer E, Scolnik D, MacPherson A, Rauchwerger D, Koren G.
Using a preprinted order sheet to reduce prescription errors in
a pediatric emergency department: a randomized, controlled
trial. Pediatrics. 2005;116:1299---302.
36. Raja Lope RJ, Boo NY, Rohana J, Cheah FC. A quality assur-
ance study on the administration of medication by nurses in
a neonatal intensive care unit. Singapore Med J. 2009;50:
68---72.
Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.

More Related Content

What's hot

Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study   Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study Kunal Modak
 
FIBRILACION AURICULAR EN URGENCIAS THE After Study
FIBRILACION AURICULAR EN URGENCIAS  THE After StudyFIBRILACION AURICULAR EN URGENCIAS  THE After Study
FIBRILACION AURICULAR EN URGENCIAS THE After Studyjasar
 
May 25, 2021 Perioperative Geriatrics
May 25, 2021   Perioperative GeriatricsMay 25, 2021   Perioperative Geriatrics
May 25, 2021 Perioperative GeriatricsCamilla Wong
 
Alvarado Syst Rv
Alvarado Syst RvAlvarado Syst Rv
Alvarado Syst RvNHS
 
Moving toward comprehensive
Moving toward comprehensiveMoving toward comprehensive
Moving toward comprehensivedrucsamal
 
Perioperative delirium
Perioperative deliriumPerioperative delirium
Perioperative deliriumCamilla Wong
 
08 exemplo de revisão sistemática
08   exemplo de revisão sistemática08   exemplo de revisão sistemática
08 exemplo de revisão sistemáticagisa_legal
 
Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research Salford Systems
 
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...vita kusuma
 
Geriatric Oncology
Geriatric OncologyGeriatric Oncology
Geriatric OncologyCamilla Wong
 
Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statinEmy Oktaviani
 
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...soad shedeed
 
00000542 200710000-00007
00000542 200710000-0000700000542 200710000-00007
00000542 200710000-00007Juan Siri
 

What's hot (18)

Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study   Journal Club presentation on Outbreak Investigation Study
Journal Club presentation on Outbreak Investigation Study
 
FIBRILACION AURICULAR EN URGENCIAS THE After Study
FIBRILACION AURICULAR EN URGENCIAS  THE After StudyFIBRILACION AURICULAR EN URGENCIAS  THE After Study
FIBRILACION AURICULAR EN URGENCIAS THE After Study
 
May 25, 2021 Perioperative Geriatrics
May 25, 2021   Perioperative GeriatricsMay 25, 2021   Perioperative Geriatrics
May 25, 2021 Perioperative Geriatrics
 
Us e fetal
Us e fetalUs e fetal
Us e fetal
 
Alvarado Syst Rv
Alvarado Syst RvAlvarado Syst Rv
Alvarado Syst Rv
 
Moving toward comprehensive
Moving toward comprehensiveMoving toward comprehensive
Moving toward comprehensive
 
Perioperative delirium
Perioperative deliriumPerioperative delirium
Perioperative delirium
 
Nejmoa1507688 (1) (1)
Nejmoa1507688 (1) (1)Nejmoa1507688 (1) (1)
Nejmoa1507688 (1) (1)
 
08 exemplo de revisão sistemática
08   exemplo de revisão sistemática08   exemplo de revisão sistemática
08 exemplo de revisão sistemática
 
P.natal
P.natalP.natal
P.natal
 
HLHS WJPCHS
HLHS WJPCHSHLHS WJPCHS
HLHS WJPCHS
 
Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research Classification and Regression Tree Analysis in Biomedical Research
Classification and Regression Tree Analysis in Biomedical Research
 
Aderenta si riscul cardiovascul
Aderenta si riscul cardiovasculAderenta si riscul cardiovascul
Aderenta si riscul cardiovascul
 
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
Sex Differences in Clinical Characteristics and Outcomes after Intracerebral ...
 
Geriatric Oncology
Geriatric OncologyGeriatric Oncology
Geriatric Oncology
 
Meta analisis of statin
Meta analisis of statinMeta analisis of statin
Meta analisis of statin
 
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
 
00000542 200710000-00007
00000542 200710000-0000700000542 200710000-00007
00000542 200710000-00007
 

Viewers also liked

Has e aterosclerose
Has e ateroscleroseHas e aterosclerose
Has e aterosclerosegisa_legal
 
Incidência de CC na sínd de Down
Incidência de CC na sínd de DownIncidência de CC na sínd de Down
Incidência de CC na sínd de Downgisa_legal
 
Tto de has em cr
Tto de has em crTto de has em cr
Tto de has em crgisa_legal
 
Thrombosis in children with bt shunts, glenns and fontans
Thrombosis in children with bt shunts, glenns and fontansThrombosis in children with bt shunts, glenns and fontans
Thrombosis in children with bt shunts, glenns and fontansgisa_legal
 
Diretriz valvopatias 2011
Diretriz valvopatias   2011Diretriz valvopatias   2011
Diretriz valvopatias 2011gisa_legal
 
Ms no exercício e no esporte
Ms no exercício e no esporteMs no exercício e no esporte
Ms no exercício e no esportegisa_legal
 
Hypertension 2013-rosner-247-54
Hypertension 2013-rosner-247-54Hypertension 2013-rosner-247-54
Hypertension 2013-rosner-247-54gisa_legal
 
Detecção pré natal de cc resultado de programa preliminar
Detecção pré natal de cc   resultado de programa preliminarDetecção pré natal de cc   resultado de programa preliminar
Detecção pré natal de cc resultado de programa preliminargisa_legal
 
Guia de doenças raras 2011
Guia de doenças raras 2011Guia de doenças raras 2011
Guia de doenças raras 2011gisa_legal
 
Diretriz valvopatias 2011
Diretriz valvopatias   2011Diretriz valvopatias   2011
Diretriz valvopatias 2011gisa_legal
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the  fetus with non cardiac diseaseFunctional echocardiography in the  fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseasegisa_legal
 
Tto de sc assintomático
Tto de sc assintomáticoTto de sc assintomático
Tto de sc assintomáticogisa_legal
 
Pediatrics 2013- sreening para has
Pediatrics 2013- sreening para hasPediatrics 2013- sreening para has
Pediatrics 2013- sreening para hasgisa_legal
 
Defeitos congenitos no rs
Defeitos congenitos no rsDefeitos congenitos no rs
Defeitos congenitos no rsgisa_legal
 
Pediatrics 2011--aterosclerose
Pediatrics 2011--aterosclerosePediatrics 2011--aterosclerose
Pediatrics 2011--aterosclerosegisa_legal
 
Sudden cardiac death in adolescents
Sudden cardiac death in adolescentsSudden cardiac death in adolescents
Sudden cardiac death in adolescentsgisa_legal
 
Avaliação e tto de sc em criança
Avaliação e tto de sc em criançaAvaliação e tto de sc em criança
Avaliação e tto de sc em criançagisa_legal
 
Obstrução de BT na T4F
Obstrução de BT na T4FObstrução de BT na T4F
Obstrução de BT na T4Fgisa_legal
 
Pediatric hypertension a growing problem
Pediatric hypertension a growing problemPediatric hypertension a growing problem
Pediatric hypertension a growing problemgisa_legal
 

Viewers also liked (20)

Pa em neonato
Pa em neonatoPa em neonato
Pa em neonato
 
Has e aterosclerose
Has e ateroscleroseHas e aterosclerose
Has e aterosclerose
 
Incidência de CC na sínd de Down
Incidência de CC na sínd de DownIncidência de CC na sínd de Down
Incidência de CC na sínd de Down
 
Tto de has em cr
Tto de has em crTto de has em cr
Tto de has em cr
 
Thrombosis in children with bt shunts, glenns and fontans
Thrombosis in children with bt shunts, glenns and fontansThrombosis in children with bt shunts, glenns and fontans
Thrombosis in children with bt shunts, glenns and fontans
 
Diretriz valvopatias 2011
Diretriz valvopatias   2011Diretriz valvopatias   2011
Diretriz valvopatias 2011
 
Ms no exercício e no esporte
Ms no exercício e no esporteMs no exercício e no esporte
Ms no exercício e no esporte
 
Hypertension 2013-rosner-247-54
Hypertension 2013-rosner-247-54Hypertension 2013-rosner-247-54
Hypertension 2013-rosner-247-54
 
Detecção pré natal de cc resultado de programa preliminar
Detecção pré natal de cc   resultado de programa preliminarDetecção pré natal de cc   resultado de programa preliminar
Detecção pré natal de cc resultado de programa preliminar
 
Guia de doenças raras 2011
Guia de doenças raras 2011Guia de doenças raras 2011
Guia de doenças raras 2011
 
Diretriz valvopatias 2011
Diretriz valvopatias   2011Diretriz valvopatias   2011
Diretriz valvopatias 2011
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the  fetus with non cardiac diseaseFunctional echocardiography in the  fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac disease
 
Tto de sc assintomático
Tto de sc assintomáticoTto de sc assintomático
Tto de sc assintomático
 
Pediatrics 2013- sreening para has
Pediatrics 2013- sreening para hasPediatrics 2013- sreening para has
Pediatrics 2013- sreening para has
 
Defeitos congenitos no rs
Defeitos congenitos no rsDefeitos congenitos no rs
Defeitos congenitos no rs
 
Pediatrics 2011--aterosclerose
Pediatrics 2011--aterosclerosePediatrics 2011--aterosclerose
Pediatrics 2011--aterosclerose
 
Sudden cardiac death in adolescents
Sudden cardiac death in adolescentsSudden cardiac death in adolescents
Sudden cardiac death in adolescents
 
Avaliação e tto de sc em criança
Avaliação e tto de sc em criançaAvaliação e tto de sc em criança
Avaliação e tto de sc em criança
 
Obstrução de BT na T4F
Obstrução de BT na T4FObstrução de BT na T4F
Obstrução de BT na T4F
 
Pediatric hypertension a growing problem
Pediatric hypertension a growing problemPediatric hypertension a growing problem
Pediatric hypertension a growing problem
 

Similar to Avaliação medicação em pediatria

Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxalfredacavx97
 
Medication errors in pediatric prescriptions
Medication errors in pediatric prescriptionsMedication errors in pediatric prescriptions
Medication errors in pediatric prescriptionsSalmanShah68
 
Medication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptxMedication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptxLatha Venkatesan
 
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Paul Pasco
 
Measurement of medication adherence
Measurement of medication  adherenceMeasurement of medication  adherence
Measurement of medication adherenceVishwasATL
 
V O L U M E 3 4 - N U M B E R 4 - F A L L 2 0 1 6 187FEATURE ART.docx
V O L U M E  3 4 -  N U M B E R  4 -  F A L L  2 0 1 6  187FEATURE ART.docxV O L U M E  3 4 -  N U M B E R  4 -  F A L L  2 0 1 6  187FEATURE ART.docx
V O L U M E 3 4 - N U M B E R 4 - F A L L 2 0 1 6 187FEATURE ART.docxkdennis3
 
PIP-Medication Errors
PIP-Medication ErrorsPIP-Medication Errors
PIP-Medication ErrorsHenry Snyder
 
PROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHUPROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHUhimanshu jain
 
Final dissertation
Final dissertationFinal dissertation
Final dissertationAjeetRai13
 
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...Capgemini
 
Addressing pediatric medication errors in ED setting utilizing Computerized P...
Addressing pediatric medication errors in ED setting utilizing Computerized P...Addressing pediatric medication errors in ED setting utilizing Computerized P...
Addressing pediatric medication errors in ED setting utilizing Computerized P...Arete-Zoe, LLC
 
Greengold Presentation
Greengold PresentationGreengold Presentation
Greengold Presentationsggibson
 
Translation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug DevelopmentTranslation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug DevelopmentE. Dennis Bashaw
 
Deepali%20kataria.pptx
Deepali%20kataria.pptxDeepali%20kataria.pptx
Deepali%20kataria.pptxDeepali262124
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyHA VO THI
 
Delirium in intensive_care_units__perceptions_of.6 (1)
Delirium in intensive_care_units__perceptions_of.6 (1)Delirium in intensive_care_units__perceptions_of.6 (1)
Delirium in intensive_care_units__perceptions_of.6 (1)Ahmad Ayed
 
What is a ‘medication error’
What is a ‘medication error’What is a ‘medication error’
What is a ‘medication error’saqibzaman11
 

Similar to Avaliação medicação em pediatria (20)

Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docx
 
DOC-20160815-WA0002
DOC-20160815-WA0002DOC-20160815-WA0002
DOC-20160815-WA0002
 
Medication errors in pediatric prescriptions
Medication errors in pediatric prescriptionsMedication errors in pediatric prescriptions
Medication errors in pediatric prescriptions
 
Medication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptxMedication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptx
 
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
Journal Article Analysis: Medication Errors in Overweight and Obese Pediatric...
 
Measurement of medication adherence
Measurement of medication  adherenceMeasurement of medication  adherence
Measurement of medication adherence
 
V O L U M E 3 4 - N U M B E R 4 - F A L L 2 0 1 6 187FEATURE ART.docx
V O L U M E  3 4 -  N U M B E R  4 -  F A L L  2 0 1 6  187FEATURE ART.docxV O L U M E  3 4 -  N U M B E R  4 -  F A L L  2 0 1 6  187FEATURE ART.docx
V O L U M E 3 4 - N U M B E R 4 - F A L L 2 0 1 6 187FEATURE ART.docx
 
PIP-Medication Errors
PIP-Medication ErrorsPIP-Medication Errors
PIP-Medication Errors
 
PROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHUPROJECT REPORT HIMANSHU
PROJECT REPORT HIMANSHU
 
Final dissertation
Final dissertationFinal dissertation
Final dissertation
 
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
 
Addressing pediatric medication errors in ED setting utilizing Computerized P...
Addressing pediatric medication errors in ED setting utilizing Computerized P...Addressing pediatric medication errors in ED setting utilizing Computerized P...
Addressing pediatric medication errors in ED setting utilizing Computerized P...
 
Greengold Presentation
Greengold PresentationGreengold Presentation
Greengold Presentation
 
Translation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug DevelopmentTranslation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug Development
 
Deepali%20kataria.pptx
Deepali%20kataria.pptxDeepali%20kataria.pptx
Deepali%20kataria.pptx
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderly
 
Delirium in intensive_care_units__perceptions_of.6 (1)
Delirium in intensive_care_units__perceptions_of.6 (1)Delirium in intensive_care_units__perceptions_of.6 (1)
Delirium in intensive_care_units__perceptions_of.6 (1)
 
E4P0815_PatientInterest_V6
E4P0815_PatientInterest_V6E4P0815_PatientInterest_V6
E4P0815_PatientInterest_V6
 
Emergency med pharmacist 2017 coralic a. et al
Emergency med pharmacist 2017 coralic a. et alEmergency med pharmacist 2017 coralic a. et al
Emergency med pharmacist 2017 coralic a. et al
 
What is a ‘medication error’
What is a ‘medication error’What is a ‘medication error’
What is a ‘medication error’
 

Recently uploaded

Greater Noida Call Girls : ☎ 8527673949, Low rate Call Girls
Greater Noida Call Girls : ☎ 8527673949, Low rate Call GirlsGreater Noida Call Girls : ☎ 8527673949, Low rate Call Girls
Greater Noida Call Girls : ☎ 8527673949, Low rate Call Girlsashishs7044
 
FULL ENJOY - 9953040155 Call Girls in Noida | Delhi
FULL ENJOY - 9953040155 Call Girls in Noida | DelhiFULL ENJOY - 9953040155 Call Girls in Noida | Delhi
FULL ENJOY - 9953040155 Call Girls in Noida | DelhiMalviyaNagarCallGirl
 
Roadrunner Lodge, Motel/Residence, Tucumcari NM
Roadrunner Lodge, Motel/Residence, Tucumcari NMRoadrunner Lodge, Motel/Residence, Tucumcari NM
Roadrunner Lodge, Motel/Residence, Tucumcari NMroute66connected
 
Pragati Maidan Call Girls : ☎ 8527673949, Low rate Call Girls
Pragati Maidan Call Girls : ☎ 8527673949, Low rate Call GirlsPragati Maidan Call Girls : ☎ 8527673949, Low rate Call Girls
Pragati Maidan Call Girls : ☎ 8527673949, Low rate Call Girlsashishs7044
 
Strip Zagor Extra 322 - Dva ortaka.pdf
Strip   Zagor Extra 322 - Dva ortaka.pdfStrip   Zagor Extra 322 - Dva ortaka.pdf
Strip Zagor Extra 322 - Dva ortaka.pdfStripovizijacom
 
FULL ENJOY - 9953040155 Call Girls in Dwarka Mor | Delhi
FULL ENJOY - 9953040155 Call Girls in Dwarka Mor | DelhiFULL ENJOY - 9953040155 Call Girls in Dwarka Mor | Delhi
FULL ENJOY - 9953040155 Call Girls in Dwarka Mor | DelhiMalviyaNagarCallGirl
 
Faridabad Call Girls : ☎ 8527673949, Low rate Call Girls
Faridabad Call Girls : ☎ 8527673949, Low rate Call GirlsFaridabad Call Girls : ☎ 8527673949, Low rate Call Girls
Faridabad Call Girls : ☎ 8527673949, Low rate Call Girlsashishs7044
 
How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?
How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?
How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?kexey39068
 
FULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | DelhiFULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | DelhiMalviyaNagarCallGirl
 
Call Girl Service in Karachi +923081633338 Karachi Call Girls
Call Girl Service in Karachi +923081633338 Karachi Call GirlsCall Girl Service in Karachi +923081633338 Karachi Call Girls
Call Girl Service in Karachi +923081633338 Karachi Call GirlsAyesha Khan
 
Karachi Escorts | +923070433345 | Escort Service in Karachi
Karachi Escorts | +923070433345 | Escort Service in KarachiKarachi Escorts | +923070433345 | Escort Service in Karachi
Karachi Escorts | +923070433345 | Escort Service in KarachiAyesha Khan
 
Govindpuri Call Girls : ☎ 8527673949, Low rate Call Girls
Govindpuri Call Girls : ☎ 8527673949, Low rate Call GirlsGovindpuri Call Girls : ☎ 8527673949, Low rate Call Girls
Govindpuri Call Girls : ☎ 8527673949, Low rate Call Girlsashishs7044
 
FULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | DelhiFULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | DelhiMalviyaNagarCallGirl
 
Bridge Fight Board by Daniel Johnson dtjohnsonart.com
Bridge Fight Board by Daniel Johnson dtjohnsonart.comBridge Fight Board by Daniel Johnson dtjohnsonart.com
Bridge Fight Board by Daniel Johnson dtjohnsonart.comthephillipta
 
MinSheng Gaofeng Estate commercial storyboard
MinSheng Gaofeng Estate commercial storyboardMinSheng Gaofeng Estate commercial storyboard
MinSheng Gaofeng Estate commercial storyboardjessica288382
 
Delhi Room Call Girls : ☎ 8527673949, Low rate Call girl service
Delhi Room Call Girls : ☎ 8527673949, Low rate Call girl serviceDelhi Room Call Girls : ☎ 8527673949, Low rate Call girl service
Delhi Room Call Girls : ☎ 8527673949, Low rate Call girl serviceashishs7044
 
Bur Dubai Call Girls O58993O4O2 Call Girls in Bur Dubai
Bur Dubai Call Girls O58993O4O2 Call Girls in Bur DubaiBur Dubai Call Girls O58993O4O2 Call Girls in Bur Dubai
Bur Dubai Call Girls O58993O4O2 Call Girls in Bur Dubaidajasot375
 
Burari Call Girls : ☎ 8527673949, Low rate Call Girls
Burari Call Girls : ☎ 8527673949, Low rate Call GirlsBurari Call Girls : ☎ 8527673949, Low rate Call Girls
Burari Call Girls : ☎ 8527673949, Low rate Call Girlsashishs7044
 
9654467111 Call Girls In Noida Sector 62 Short 1500 Night 6000
9654467111 Call Girls In Noida Sector 62 Short 1500 Night 60009654467111 Call Girls In Noida Sector 62 Short 1500 Night 6000
9654467111 Call Girls In Noida Sector 62 Short 1500 Night 6000Sapana Sha
 

Recently uploaded (20)

Greater Noida Call Girls : ☎ 8527673949, Low rate Call Girls
Greater Noida Call Girls : ☎ 8527673949, Low rate Call GirlsGreater Noida Call Girls : ☎ 8527673949, Low rate Call Girls
Greater Noida Call Girls : ☎ 8527673949, Low rate Call Girls
 
FULL ENJOY - 9953040155 Call Girls in Noida | Delhi
FULL ENJOY - 9953040155 Call Girls in Noida | DelhiFULL ENJOY - 9953040155 Call Girls in Noida | Delhi
FULL ENJOY - 9953040155 Call Girls in Noida | Delhi
 
Roadrunner Lodge, Motel/Residence, Tucumcari NM
Roadrunner Lodge, Motel/Residence, Tucumcari NMRoadrunner Lodge, Motel/Residence, Tucumcari NM
Roadrunner Lodge, Motel/Residence, Tucumcari NM
 
Pragati Maidan Call Girls : ☎ 8527673949, Low rate Call Girls
Pragati Maidan Call Girls : ☎ 8527673949, Low rate Call GirlsPragati Maidan Call Girls : ☎ 8527673949, Low rate Call Girls
Pragati Maidan Call Girls : ☎ 8527673949, Low rate Call Girls
 
Strip Zagor Extra 322 - Dva ortaka.pdf
Strip   Zagor Extra 322 - Dva ortaka.pdfStrip   Zagor Extra 322 - Dva ortaka.pdf
Strip Zagor Extra 322 - Dva ortaka.pdf
 
FULL ENJOY - 9953040155 Call Girls in Dwarka Mor | Delhi
FULL ENJOY - 9953040155 Call Girls in Dwarka Mor | DelhiFULL ENJOY - 9953040155 Call Girls in Dwarka Mor | Delhi
FULL ENJOY - 9953040155 Call Girls in Dwarka Mor | Delhi
 
Faridabad Call Girls : ☎ 8527673949, Low rate Call Girls
Faridabad Call Girls : ☎ 8527673949, Low rate Call GirlsFaridabad Call Girls : ☎ 8527673949, Low rate Call Girls
Faridabad Call Girls : ☎ 8527673949, Low rate Call Girls
 
How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?
How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?
How Can You Get Dubai Call Girls +971564860409 Call Girls Dubai?
 
FULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | DelhiFULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in Laxmi Nagar | Delhi
 
Call Girl Service in Karachi +923081633338 Karachi Call Girls
Call Girl Service in Karachi +923081633338 Karachi Call GirlsCall Girl Service in Karachi +923081633338 Karachi Call Girls
Call Girl Service in Karachi +923081633338 Karachi Call Girls
 
Karachi Escorts | +923070433345 | Escort Service in Karachi
Karachi Escorts | +923070433345 | Escort Service in KarachiKarachi Escorts | +923070433345 | Escort Service in Karachi
Karachi Escorts | +923070433345 | Escort Service in Karachi
 
Govindpuri Call Girls : ☎ 8527673949, Low rate Call Girls
Govindpuri Call Girls : ☎ 8527673949, Low rate Call GirlsGovindpuri Call Girls : ☎ 8527673949, Low rate Call Girls
Govindpuri Call Girls : ☎ 8527673949, Low rate Call Girls
 
Dxb Call Girls # +971529501107 # Call Girls In Dxb Dubai || (UAE)
Dxb Call Girls # +971529501107 # Call Girls In Dxb Dubai || (UAE)Dxb Call Girls # +971529501107 # Call Girls In Dxb Dubai || (UAE)
Dxb Call Girls # +971529501107 # Call Girls In Dxb Dubai || (UAE)
 
FULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | DelhiFULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | Delhi
FULL ENJOY - 9953040155 Call Girls in New Ashok Nagar | Delhi
 
Bridge Fight Board by Daniel Johnson dtjohnsonart.com
Bridge Fight Board by Daniel Johnson dtjohnsonart.comBridge Fight Board by Daniel Johnson dtjohnsonart.com
Bridge Fight Board by Daniel Johnson dtjohnsonart.com
 
MinSheng Gaofeng Estate commercial storyboard
MinSheng Gaofeng Estate commercial storyboardMinSheng Gaofeng Estate commercial storyboard
MinSheng Gaofeng Estate commercial storyboard
 
Delhi Room Call Girls : ☎ 8527673949, Low rate Call girl service
Delhi Room Call Girls : ☎ 8527673949, Low rate Call girl serviceDelhi Room Call Girls : ☎ 8527673949, Low rate Call girl service
Delhi Room Call Girls : ☎ 8527673949, Low rate Call girl service
 
Bur Dubai Call Girls O58993O4O2 Call Girls in Bur Dubai
Bur Dubai Call Girls O58993O4O2 Call Girls in Bur DubaiBur Dubai Call Girls O58993O4O2 Call Girls in Bur Dubai
Bur Dubai Call Girls O58993O4O2 Call Girls in Bur Dubai
 
Burari Call Girls : ☎ 8527673949, Low rate Call Girls
Burari Call Girls : ☎ 8527673949, Low rate Call GirlsBurari Call Girls : ☎ 8527673949, Low rate Call Girls
Burari Call Girls : ☎ 8527673949, Low rate Call Girls
 
9654467111 Call Girls In Noida Sector 62 Short 1500 Night 6000
9654467111 Call Girls In Noida Sector 62 Short 1500 Night 60009654467111 Call Girls In Noida Sector 62 Short 1500 Night 6000
9654467111 Call Girls In Noida Sector 62 Short 1500 Night 6000
 

Avaliação medicação em pediatria

  • 1. J Pediatr (Rio J). 2014;90(4):344---355 www.jped.com.br REVIEW ARTICLE Evaluation of the medication process in pediatric patients: a meta-analysisଝ Despina Koumpagiotia,∗ , Christos Varounisb , Eleni Kletsioub , Charalampia Ntelia , Vasiliki Matziouc a P & A Kyriakoy General Children’s Hospital, Athens, Greece b Attikon Hospital, Athens, Greece c Faculty of Nursing, National and Kapodistrian University, Athens, Greece Received 16 January 2014; accepted 28 January 2014 Available online 13 April 2014 KEYWORDS Medication errors; Children; Drug errors; Pediatric patients; Medication process; Meta-analysis Abstract Objective: to meta-analyze studies that have assessed the medication errors rate in pediatric patients during prescribing, dispensing, and drug administration. Sources: searches were performed in the PubMed, Cochrane Library, and Trip databases, select- ing articles published in English from 2001 to 2010. Summary of the findings: a total of 25 original studies that met inclusion criteria were selected, which referred to pediatric inpatients or pediatric patients in emergency departments aged 0-16 years, and assessed the frequency of medication errors in the stages of prescribing, dispensing, and drug administration. Conclusions: the combined medication error rate for prescribing errors to medication orders was 0.175 (95% Confidence Interval: [CI] 0.108-0.270), the rate of prescribing errors to total medication errors was 0.342 (95% CI: 0.146-0.611), that of dispensing errors to total medication errors was 0.065 (95% CI: 0.026-0.154), and that ofadministration errors to total medication errors was 0.316 (95% CI: 0.148-0.550). Furthermore, the combined medication error rate for administration errors to drug administrations was 0.209 (95% CI: 0.152-0.281). Medication errors constitute a reality in healthcare services. The medication process is significantly prone to errors, especially during prescription and drug administration. Implementation of medication error reduction strategies is required in order to increase the safety and quality of pediatric healthcare. © 2014 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved. ଝ Please cite this article as: Koumpagioti D, Varounis C, Kletsiou E, Nteli C, Matziou V. Evaluation of the medication process in pediatric patients: a meta-analysis. J Pediatr (Rio J). 2014;90:344---55. ∗ Corresponding author. E-mail: dkoumpagioti@nurs.uoa.gr (D. Koumpagioti). http://dx.doi.org/10.1016/j.jped.2014.01.008 0021-7557/© 2014 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved. Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 2. Evaluation of the medication process in pediatric patients 345 PALAVRAS-CHAVE Erros de medicac¸ão; Crianc¸as; Erros de medicamentos; Pacientes pediátricos; Processo de medicac¸ão; Meta-análise Avaliac¸ão do processo de medicac¸ão em pacientes pediátricos: meta-análise Resumo Objetivo: analisar estudos de meta-análise que avaliaram o índice de erros de medicac¸ão em pacientes pediátricos na prescric¸ão, liberac¸ão e administrac¸ão de medicamentos. Fontes dos dados: foram feitas buscas nas bases de dados Pubmed, Biblioteca Cochrane e Trip, selecionando artigos publicados em inglês de 2001 a 2010. Síntese dos dados: um total de 25 estudos originais que atenderam aos critérios de inclusão foi selecionado e está relacionado a pacientes pediátricos internados ou pacientes pediátricos nos Servic¸os de Emergência, com idades entre 0-16 anos. Esses estudos avaliaram a frequência de erros de medicac¸ão nas etapas de prescric¸ão, liberac¸ão e administrac¸ão de medicamentos. Conclusões: o índice combinado de erros de medicac¸ão para erros na prescric¸ão/solicitac¸ão de medicac¸ão foi igual a 0,175 (com intervalos de confianc¸a (IC) de 95%: 0,108-0,270); para erros na prescric¸ão/total de erros de medicac¸ão foi 0,342, com IC de 95%: 0,146-0,611; para erros na liberac¸ão/total de erros de medicac¸ão foi 0,065, com IC de 95%: 0,026-0,154; e para erros na administrac¸ão/total de erros de medicac¸ão foi 0,316, com IC de 95%: 0,148-0,550. Adicional- mente, o índice combinado de erros de medicac¸ão para erros na administrac¸ão/administrac¸ão de medicamentos foi igual a 0,209, com IC de 95%: 0,152-0,281. Erros de medicac¸ão con- stituem uma realidade nos servic¸o de saúde. O processo de medicac¸ão é significativamente propenso a erros, principalmente na prescric¸ão e administrac¸ão de medicamentos. Precisa haver a implementac¸ão de estratégias de reduc¸ão dos erros de medicac¸ão para aumentar a seguranc¸a e a qualidade na prestac¸ão de cuidados de saúde pediátrica. © 2014 Sociedade Brasileira de Pediatria. Publicado por Elsevier Editora Ltda. Todos os direitos reservados. Introduction Medication errors constitute a reality in healthcare systems, and are considered to be the most common type of medical errors, according to the Joint Commission.1 The pediatric population is under the risk of medication errors due to the wide variation in body mass, which requires unique drug doses to be calculated, based on the patient’s weight or body surface, age, and clinical condition.2 Particularly, med- ication errors with the potential to cause harm are three times more likely in pediatric inpatients than in adults.3 The great majority of medication errors in children pertain to the stages of prescription and drug administration, according the results of systematic reviews and original studies.3---6 Consequently, according to the National Coordinating Council for Medication Error Reporting and Prevention, the aim of each healthcare organization should be the con- stant improvement of its systems in order to prevent harm caused by medication errors.7 Thus, the development of medication error reduction strategies is an important part of ensuring the safety and quality of patient care in pedi- atric population.8 The aim of this study was to meta-analyze studies that have evaluated the frequency of pediatric medication errors during prescribing, dispensing, and drug administration, in order to highlight the vulnerability to errors of each step, and to improve medication process, leading to error reduction. Methods Definitions terms For the needs of this meta-analysis, some basic defini- tions related to the medication errors were used, with the approval of the review of the institution. The definition of medication process includes prescribing, transcribing or documenting, dispensing, administering, and monitoring the patient.9 Medication error is considered as every error dur- ing the medication use process.10 Prescribing errors include incomplete, incorrect, inappropriate request at the time of physician order, illegibility and/or need for further interpre- tation, or any missing route, interval, concentration, rate, dose, and patient data (such as weight, age, or allergies).11 Dispensing error is assumed as any deviation or error deriv- ing from the receipt of the prescription in the pharmacy to the supply of a dispensed medicine to the patient.12 Finally, administration error is defined as any discrepancy occur- ring between the drug received by the patient and the drug therapy intended by the physician.12 Literature review A systematic literature review was conducted from January of 2001 to December of 2010 using the PubMed, Cochrane, and Trip databases, using the key words ‘‘medication errors’’, ‘‘children’’, ‘‘drug errors’’, ‘‘pediatric patients’’, ‘‘medication process’’, and ‘‘meta-analysis’’. The litera- ture search was based on original studies that met the inclusion criteria quoted below: • Studies published in English from January 1, 2001 to December 31, 2010. • Studies that referred to pediatric inpatients or pediatric patients in emergency departments. • Studies that included patients aged 0 to 16 years. • Studies that assessed the frequency of medication errors in the stages of prescribing, dispensing, and drug admin- istration. Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 3. 346 Koumpagioti D et al. • Studies that had the same numerators and denominators for the data grouping. The exclusion criteria involved studies with incomplete data whose clarification was not feasible, despite the researchers’ assistance for the retrieval of required infor- mation. Furthermore, the exclusion criteria involved studies that exclusively referred to: • pediatric outpatients; • specific drug categories, such as cardiological and anti- neoplastics, among others; • specific patient categories, such as oncology; and • adverse drug events (ADEs). The studies used for this meta-analysis contained clear and unambiguous data related to pediatric medication errors, in these three stages of the process of medica- tion, and described the frequency of medication errors in each stage. The majority of these studies were systematic reviews, and their quality was assessed through the use of two scales. Due to the absence of a universal scale for the quality assessment of observational studies (that constitute the majority of the studies involved in this meta-analysis), and following the recommendations of the meta-analysis of observational studies in epidemiology guidelines,13 the qual- ity of key design components was assessed separately, and then used to generate a single aggregate score.14 For the measurement of cohort studies quality, a scale of four ques- tions (such as cohort inclusion criteria, exposure definition, clinical outcomes, and adjustment for confounding varia- bles) was used, while each question was scored on a scale of 0 to 2, with a maximum quality score of 8, representing the highest quality score.14 The quality of the one randomized clinical control trial was assessed by a modified Jadad scale with a maximum of 3 points. A maximum of 2 points were earned for the randomization method, and a maximum of 1 point for the description of withdrawals and dropouts.15 Two independent reviewers screened the title and the abstract of each study for their correspondence to the inclusion criteria. In full text articles, two reviewers decided their eligibility, while the relevant information was extracted sequentially, so that the second reviewer was able to study the first reviewer’s extracted information. Statistical Analysis For each study, the following error rates were computed from the reported data: prescribing errors to medication orders, prescribing errors to total medication errors, dis- pensing errors to total medication errors, administration errors to total medication errors, and administration errors to drug administrations. For each error rate, the pooled estimates and 95% confidence intervals (95% CIs) were cal- culated using the random effects model, due to evidence of significant heterogeneity. Heterogeneity was investigated by use of I2 statistic. Publication bias was tested statistically with Egger’s test, which estimates the publication bias by linear regression approach. Analyses were performed using the Comprehensive Meta-Analysis software (Comprehensive Meta-Analysis Software) (CMA) (Biostat, Inc.). CMA uses computational algorithms to weight studies by inverse vari- ance. Statistical significance was set at a p-value level of 0.05. Results Literature search Through the systematic literature review, 921 original stud- ies and systematic reviews were identified, while 775 of those were excluded due to the absence of subject rele- vance, and 57 because they were systematic reviews. 89 studies remained and were evaluated further, while 20 of those were rejected due to the existence of the same stud- ies in different databases. Finally, from the remaining 69 studies, 44 were excluded because they didn’t meet the inclusion criteria. Consequently, 25 original studies were included in this meta-analysis. Fig. 1 represents the flow diagram and provides an overview of the literature review and studies’ selection. Characteristics of the studies Table 1 shows the basic characteristics of the 25 studies included in the meta-analysis. In a total of 25 studies, there were nine cohort studies,3,5,11,16---21 three retrospective cohort studies,22---24 seven retrospec- tive studies,4,25---30 two interventional studies,31,32 one quasi-experimental study,33 one cross-sectional study,34 one randomized controlled trial,35 and one observa- tional study.36 Furthermore, the majority of the studies relied on chart review for the data collection (17 of 25),3,5,11,18,20---22,24,26---32,34,35 while four of the 25 studies relied on error reporting systems,4,17,18,23,25 three of 25 studies on observation,16,19,36 and one study on chart review and interviews.33 Regarding the types of medication errors iden- tified through these studies, nine of 25 reported prescribing errors;11,24,26,28,30---33,35 three of 25 studies, administration errors;16,19,36 five of 25 studies, prescribing and administra- tion errors;21,22,29,34 seven studies, all types of medication errors;3---5,17,18,23,25 and one study reported prescribing and dispensing errors.27 Finally, 17 studies referred to pediatric inpatients,3---5,11,16---21,23,25,28,31---32,34,36 seven studies to pedi- atric patients in emergency departments,22,24,26,29,30,33,35 and one study to pediatric inpatients and patients in emergency departments.27 In studies in which there was intervention,5,11,17---18,21,23---24,28,29,31---36 data was obtained from phase I only, as presented in Table 1. Therefore, great heterogeneity between the studies was observed, due to the difference in parameters and condi- tions used for the data collection. Significant heterogeneity was observed in the manner that medication errors and their categories were defined by each study. Namely, there were studies in which administration errors included every error from the stage of drug dispensing in the ward by the nursing staff to drug administration, such as those by Chua et al.,19 Fontan et al.,21 and Jain et al.27 These studies, in this meta- analysis, were classified in the category of administration Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 4. Evaluationofthemedicationprocessinpediatricpatients347 Table 1 Characteristics of the studies included in the meta-analysis. Studies Study Design Setting Duration Instruments used for the data collection Error types Results Quality Cowley et al.,4 2001 USA Retrospective Pediatric Inpatients 01/1999 ---12/2000 Error reporting system All types 143 prescribing errors, 449 dispensing errors, 1007 administration errors, in a total of 1,956 medication errors - Kaushal et al.,3 2001 USA Cohort PICU, Medical/surgical wards, short-stay medical ward 04/1999 ---05/1999 Chart review All types 454 prescribing errors, 6 dispensing errors, 78 administration errors, in a total of 616 medication errors 7 Sangtawesin et al.,25 2003 Thailand Retrospective PICU, NICU 09/2001 ---11/2002 Error reporting system All types 114 prescribing errors, 112 dispensing errors, 49 administration errors, in a total of 322 medication errors - Kozer et al.,22 2002 Canada Retrospective cohort Emergency department 12 randomly days of 2000 Chart review Prescribing, administration 271 prescribing errors per 1,678 medication orders, 59 administration errors per 1,532 charts 7 Cimino et al.,31 2004 USA Interventional PICU 2 weeks Chart review Prescribing 3,259 errors per 12,026 medication orders - Potts et al.,11 2004 USA Cohort PICU 10/2001 ---12/2001 (1st phase) Chart review Prescribing 2,049 errors per 6,803 medication orders 6 Prot et al.,16 2005 France Cohort PICU, NICU, general pediatric, and nephrological unit 04/2002 ---03/2003 Observation Administration 538 errors per 1,719 drug administrations 7 Frey et al.,17 2002 Switzerland Cohort PICU 01/01/2000 ---31/12/2000 Error reporting system All types 102 prescribing errors, 162 dispensing errors, 200 administration errors in a total of 275 medication errors 7
  • 5. 348KoumpagiotiDetal. Table 1 (Continued ) Studies Study Design Setting Duration Instruments used for the data collection Error types Results Quality Porter et al.,33 2008 USA Quasi- experimental Emergency department 06/2005 ---06/2006 Chart review, interviews Prescribing 1,755 errors per 2,234 medication orders - Taylor et al.,26 2005 USA Retrospective Emergency department 01/1998 -06/1998 Chart review Prescribing 311 errors per 358 medication orders - Wang et al.,18 2007 USA Cohort PICU, NICU, pediatric ward 02/2002 ---04/2002 Chart review, error reporting system All types 464 prescribing errors, 2 dispensing errors, 101 administration errors in a total of 865 medication errors 6 King et al.,23 2003 Canada Retrospective cohort Medical and surgical ward 04/1993 ---03/1996 (1st phase) Error reporting system All types 13 prescribing errors, 19 dispensing errors, 314 administration errors in a total of 416 medication errors 7 Kozer et al.,35 2005 Canada Randomized control clinical trial Emergency department 07/2001 Chart review Prescribing 68 errors per 411 medication orders 3 (Jadad score) Otero et al.,34 2008 Argentina Cross- sectional ICU, NICU pediatrics clinic 06/2002 (1st phase) Chart review Prescribing, administration 102 prescribing errors per 590 medication orders 99 administration errors per 1,174 drug administrations - Fortescue et al.,5 2003 USA Cohort PICU, NICU, short-stay medical ward, medical/ surgical ward 04/1999 ---05/1999 Chart review All types 479 prescribing errors, 6 dispensing errors, 79 administration errors in a total of 616 medication errors 5 Chua et al.,19 2010 Malaysia Cohort Pediatric ward 11/2004 ---01/2005 Observation Administration 100 errors per 857 drug administrations 5 Ghaleb et al.,20 2010 UK Cohort PICU, NICU medical and surgical ward 2004- 2005 for 22 weeks Chart review Prescribing, administration 391 prescribing errors per 2,955 medication orders 429 administration errors per 1,544 drug administrations 5
  • 6. Evaluationofthemedicationprocessinpediatricpatients349 Table 1 (Continued ) Studies Study Design Setting Duration Instruments used for the data collection Error types Results Quality Fontan et al.,21 2003 France Cohort Nephrological Unit 02/1999 ---03/1999 Chart review Prescribing, administration 937 prescribing errors per 4,532 medication orders 1077 administration errors per 4,135 drug administrations 6 Raja Lope et al.,36 Malaysia Observational NICU 02/2005 (1st phase) Observation Administration 59 errors per 188 drug administrations - Sard et al.,24 2008 USA Retrospective cohort Emergency department 2005 Chart review Prescribing 101 errors per 326 medication orders 7 Jain et al.,27 2009 India Retrospective PICU, Emergency department 01/2004 ---04/2004 Chart review Prescribing, dispensing 67 prescribing errors & 14 dispensing errors per 821 medication orders - Kadmon et al.,28 2009 Israel Retrospective PICU 09/2001 (1st phase) Chart review Prescribing 103 errors per 1,250 medication orders - Larose et al.,29 2008 Canada Retrospective Emergency department 2003 (1st phase) Chart review Prescribing, administration 32 prescribing errors & 23 administration errors per 372 medication orders - Rinke et al.,30 2008 USA Retrospective Emergency department 04/2005 ---09/2005 Chart review Prescribing 81 errors per 1,073 medication orders - Campino et al.,32 2009 Spain Interventional NICU 09/2005- 02/2006 Chart review Prescribing 868 errors per 4,182 medication orders - PICU, pediatric intensive care unit; NICU, neonatal intensive care unit
  • 7. 350 Koumpagioti D et al. Studies screened for retrieval • Pubmed: n=862 • Cochrane: n=38 • Trip database: n=21 Total: n=921 n=775 studies excluded for non-relevant subject n = 89 studies retrieved for further evaluation n=69 studies potentially appropriate n=20 excluded (duplicates) 44 studies excluded for: • n=11 exclusively referring to pediatric outpatients • n=12 for specific drug categories • n=5 for specific patient categories • n=10 for adverse drug events • n=6 due to incomplete data n=57 studies excluded (systematic reviews) Ν=25 original studies used in the meta-analysis while they met the inclusion criteria Figure 1 Flow diagram of studies included in the meta-analysis. errors. In other studies, dispensing errors were defined as errors during drug dispensing by the pharmacist.5,8,17,18,23,25 Difference was also noticed between the definitions of prescribing errors across the studies. While the majority of the studies used the broadest sense of the term ‘‘prescribing error’’,20,24,26,29,32---34 as the one used for this meta-analysis, there were studies that used the term prescribing error solely as any incomplete or ambiguous order.11,28 Moreover, there was a differentiation in the instruments used for the data collection by each study, the studies’ design, the age groups that took part in each study, the sett- ings, and the numerators and denominators used by each study for the assessment of the frequency of medication error occurrence. Statistical Results For the purposes of this study, five groups based on com- mon numerators and denominators were combined. The numerator and the denominator of each study constitute the estimated relative measure. Through the use of the esti- mated relative measure (numerator/denominator) of each study, integrated error rates were calculated for each of these groups. Most studies participated in more than one group. The first group, specifically, included prescribing errors in relation to the medication orders. The prescrib- ing errors were defined as numerators and the medication orders as denominators. The prescribing error rate per medication orders was calculated as 0.175 (95% CI: 0.108- 0.270; p-value < 0.001). The second group related to prescribing errors (numerator) and total medication errors (denominator). The integrated prescribing error rate was 0.342 (95% CI: 0.146-0.611; p-value = 0.246). The third group included dispensing errors (numerator) and total medication errors (denominator). The total dispensing error rate was estimated as 0.065 (95% CI: 0.026-0.154; p-value < 0.001). The fourth group consisted of administration errors as numerator and total medication errors as denominator, with a total administration error rate of 0.316 (95% CI: 0.148-0.550; p-value = 0.119). Finally, the fifth group con- tained administration errors per drug administration. The integrated administration error rate was 0.209, (95% CI: 0.152-0.281; p-value < 0.001). Prescribing errors per medication orders Eighteen studies were used for this group. Nine of 18 studies referred exclusively to prescribing errors;11,26,30---33,35 five of 18, to prescribing and administration errors;20---22,29,34 one of 18, to prescribing and dispensing errors;27 and three of 18, to all types of errors.3,5,18 Furthermore, all studies comprised by this group clearly described the number of medication orders, screened for prescribing errors. On Fig. 2, all 18 studies are represented, as well as the error rates of each study (from the ratio of prescribing errors per medication orders of each study) and the random effect rate. In a total of 78,135 medication orders from these 18 studies, Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 8. Evaluation of the medication process in pediatric patients 351 Error rate: the frequency of prescription errors per medication Studies Error rate Lower limit Upper limit Z-score p-value Jain et al.27 0.082 0.065 0.102 –18.989 0.000 Kadmon et al.28 0.082 0.068 0.099 –23.431 0.000 Ghaleb et al.20 0.132 0.121 0.145 –34.639 0.000 Otero et al.34 0.173 0.144 0.206 –14.378 0.000 Larose et al.29 0.086 0.061 0.119 –12.780 0.000 Porter et al.33 0.786 0.768 0.802 25.189 0.000 Rinke et al.30 0.075 0.061 0.093 –21.680 0.000 Campino et al.32 0.208 0.196 0.220 –35.136 0.000 Sard et al.24 0.310 0.262 0.362 –6.688 0.000 Wang et al.18 0.027 0.025 0.030 –75.832 0.000 Kozer et al.35 0.165 0.133 0.205 –12.190 0.000 Taylor et al.26 0.869 0.830 0.900 12.074 0.000 Cimino et al.31 0.271 0.263 0.279 –48.234 0.000 Potts et al.11 0.391 0.380 0.403 –17.787 0.000 Fortescue et al.5 0.044 0.041 0.048 –65.640 0.000 Fontan et al.21 0.207 0.195 0.219 –36.658 0.000 Kozer et al.22 0.162 0.145 0.180 –24.829 0.000 Kaushal et al.2 0.042 0.038 0.046 –65.150 0.000 0.175 0.108 0.270 –5.461 0.000 –1.00 –0.50 0.00 0.50 1.00 I2 = 99.8%. p < 0.001 Egger’s test: a = –10.58, p = 0.32 Error rate and 95% CI Figure 2 The estimated relative measures for prescription errors per medication order, with 95% CIs (95% Confidence Intervals), the integrated error rate, and the forest plot. the integrated error rate was calculated as 0.175, (95% CI: 0.108-0.270;and p-value < 0.001). In Fig. 2, the forest plot is illustrated. The vertical axis of the forest plot represents the studies, while the horizontal axis, the estimated rel- ative measures. Squares illustrate the estimated relative measures of each study and the diamond, the integrated error rate calculated through the random effect model. No potential publication bias was found by Egger’s test (intercept a = −0.400;95% CI: -1.594 to 0.792; p = 0.443). Moreover, the heterogeneity between the studies was very high, as investigated by the I2 statistic (I2 = 99.8%; p < 0.001). Prescribing errors per total medication errors In this group, seven studies3,4,17,18,23,25 concerning all types of errors with the inclusion of prescribing errors were included. Fig. 3 provides an overview of the referred studies with their error rates. The integrated prescribing error rate estimated in a total of 5,066 medication errors from these seven studies was 0.342 (95% CI: 0.146-0.611; p-value = 0.246).Additionally, in the forest plot, the signif- icant heterogeneity between the studies is illustrated, as the estimated relative measures of each study (squares) are distributed heterogeneously around the integrated error rate (diamond). No potential publication bias was found by Egger’s test (intercept a = -12.40; 95% CI: -60.19 to 35.39; p > 0.05), and very high heterogeneity as I2 > 50% (I2 = 99.5%; p < 0.001). Dispensing errors per total medication errors The same seven studies3,4,17,18,23,25 used for this group refer to all types of errors, including dispensing errors. An overview of the studies and the forest plot is showcased in Fig. 4. The integrated dispensing error rate was 0.065 Studies Wang et al.18 Fortescue et al.5 Sangtawesin et al.25 King et al.23 Frey et al.17 Kaushal et al.3 Cowley et al.4 Ι2 = 99.5%. p < 0.001 Egger’s test: a = –12.40, p = 0.53 Error rate 0.536 0.778 0.354 0.031 0.371 0.737 0.073 0.342 Lower limit 0.503 0.743 0.304 0.018 0.316 0.701 0.062 0.146 Upper limit 0.569 0.809 0.408 0.053 0.430 0.770 0.086 0.611 Z-score 2.140 12.919 –5.160 –12.186 –4.232 11.260 –29.241 –1.161 Error rate: The frequency of prescription errors per total medication errors. p-value 0.032 0.000 0.000 0.000 0.000 0.000 0.000 0.246 –1.00 –0.50 0.00 0.50 1.00 Error rate and 95% CI Figure 3 The estimated relative measures for prescription errors per total medication errors, with 95% CIs (95% Confidence Intervals), the integrated error rate, and the forest plot. Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 9. 352 Koumpagioti D et al. Studies Wang et al.18 Fortescue et al.5 Sangtawesin et al.25 King et al.23 Frey et al.17 Kaushal et al.3 Cowley et al.4 Ι2 = 98.6%. p < 0.001 Egger’s test: a = –6.59, p = 0.21 Error rate 0.002 0.010 0.348 0.046 0.589 0.010 0.230 0.065 Lower limit 0.001 0.004 0.298 0.029 0.530 0.004 0.211 0.026 Upper limit 0.009 0.022 0.401 0.070 0.646 0.022 0.249 0.154 Z-score –8.570 –11.266 –5.372 –12.943 2.939 –11.266 –22.521 –5.416 Error rate: The frequency of dispensing errors per total medicationerrors. p-value 0.000 0.000 0.000 0.000 0.003 0.000 0.000 0.000 Error rate and 95 % CI –1.00 –0.50 0.00 0.50 1.00 Figure 4 The estimated relative measures for dispensing errors per total medication errors, with 95% CIs (95% Confidence Intervals), the integrated error rate, and the forest plot. (95% CI: 0.026-0.154; p-value < 0.001). Consequently, in a total of 5,066 medication errors, the random effect rate was measured to 6.5%. No potential publication bias was found by Egger’s test (intercept a = -6.50; 95% CI: -18.17 to 5.15; p = 0.21), and very high heterogeneity as I2 > 50% (I2 = 98.6%; p < 0.001). Administration errors per total medication errors The same seven studies3,4,17,18,23,25 included in this group reported all types of medication errors, as well as dispens- ing errors. Fig. 5 shows the estimated relative measures for each study, and the forest plot presents the distribu- tion of the studies around the integrated error rate. The administration error rate was 0.316 (95% CI: 0.148-0.550; p- value = 0.119). Thus, in a total of 5,066 medication errors, the random effect rate was 31.6%. No potential publication bias was found by Egger’s test (intercept a = -11.70; 95% CI: -39.90 to 16.49; p = 0.33), and very high heterogeneity as I2 > 50% (I2 = 98.6%, p < 0.001). Administration errors per drug administrations Six studies16,19---21,34,36 with common numerators (administra- tion errors) and denominators (drug administrations) were chosen for this group. For each study, the estimated rel- ative measures were calculated, as well as the integrated administration error rate, which measured 0.209 (95% CI: 0.152-0.281; p-value < 0.001). Fig. 6 provides an overview of the ratios of administration errors per drug administration and the forest plot that illustrates the studies’ contribu- tion to the value of the integrated error rate. In a total of 9,167 drug administrations, from these six studies, the random effect error rate was as 20.9%. No potential publication bias was found by Egger’s test (intercept a = -8.28; 95% CI: -25.95 to 9.38; p = 0.26), and very high heterogeneity as I2 > 50% (I2 = 98.2%; p < 0.001). Discussion Medication errors cause serious problems in daily clinical practice and are of significant concern, especially for the pediatric population. Many of the members of the disci- plinary team may be involved in the causation of medication errors, such as clinicians, nurses, pharmacists, although there is great speculation regarding their management and reduction. In this meta-analysis, the authors tried to esti- mate a more integrated result in relation to the frequency and nature of medication errors in pediatric patients, dur- ing the stages of prescribing, dispensing, and administration. For this objective, five different groups were created, after a careful selection of studies that met the goals of each group. Therefore, the integrated rate in relation to the pre- scribing errors per medication order was calculated as0.175, and in relation to the prescribing errors per total medication errors, dispensing errors per total medication errors, and administration errors per total medication errors were cal- culated as 0.342, 0.065, and 0.316, respectively. Moreover, the integrated rate for the ratio of administration errors per drug administration was estimated as 0.209. This study highlighted the most vulnerable stages in the medication use process. The highest rates were observed in prescribing and drug administration, managed by clinicians and nurses, respectively. Additionally, comparing the results between the groups, the predominance of prescribing errors can be discerned, followed by administration errors; dis- pensing errors had the lowest rates. Due to the absence of other meta-analyses in relation to medication errors in children, it’s impossible to compare the results with other studies. Therefore, because of the occurrence of systematic reviews, the two stages of medication process (prescribing and administration) present the highest error rates, as shown in the study by Miller et al., in which prescribing errors varied between 3% and 37% and administration errors between 72% and 75%.6 Moreover, according to the review of eight studies, which used observation for administration error identification, Ghaleb et al. highlighted administra- tion error rates per drug administration of 0.6% to 27%.2 These rates agree with that of the present meta-analysis, which was calculated as 20.9%. Moreover, Miller et al. estimated that 5% to 27% of medication orders for children contained an error throughout the entire medication pro- cess, involving prescribing, dispensing, and administration, based on three studies;6 in the current meta-analysis, the integrated error rate for prescribing errors per medication order approached 17.5%. Dispensing errors, conversely, presented the lowest rate (6.5%), in contrast to the other two stages of the medi- cation use process. However, in the study by Miller et al., Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 10. Evaluation of the medication process in pediatric patients 353 C Studies Wang et al.18 Fortescue et al.5 Sangtawesin et al.25 King et al.23 Frey et al.17 Kaushal et al.3 Cowley et al.4 Ι2 = 98.6%. p < 0.001 Egger’s test: a = –11.70, p = 0.33 0.117 0.128 0.152 0.755 0.727 0.127 0.515 0.316 Error rate Lower limit 0.097 0.104 0.117 0.711 0.672 0.103 0.493 0.148 Upp er limit 0.140 0.157 0.196 0.794 0.777 0.155 0.537 0.550 Z-score –19.111 –15.905 –11.071 9.866 7.244 –15.939 1.311 –1.559 p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.190 0.119 Error rate: The frequency of administration errors per total medication errors. Error rate and 95% CI –1.00 –0.50 0.00 0.50 1.00 Figure 5 The estimated relative measures for administration errors per total medication errors, with 95% CIs (95% Confidence Intervals), the integrated error rate, and the forest plot. Studies Raja Lope et al.36 Ghaleb et al.2 Otero et al.34 Prot et al.16 Chua et al.19 Fontan et al.21 Ι2 = 98.2%. p < 0.001 Egger’s test: a = –8.28, p = 0.26 Error rate 0.117 0.314 0.276 0.084 0.070 0.313 0.260 0.209 Lower limit 0.097 0.254 0.291 0.247 0.152 Upper limitt 0.140 0.252 0.384 0.299 0.102 0.335 0.274 0.281 Z-score –19.024 –4.977 –16.990 –22.707 –15.116 –29.452 –6.676 p-value 0.000 0.000 0.000 0.000 0.000 0.000 0.000 Error rate: the frequency of administration errors per total drug administrations. –0.50 –0.25 0.00 0.25 0.50 Error rate and 95%% CI Figure 6 The estimated relative measures for administration errors per drug administrations, with 95% CIs (95% Confidence Intervals), the integrated error rate, and the forest plot. the dispensing error rates ranged between 5% and 58%, as calculated through the use of three studies, due to the het- erogeneity presented in the others studies.6 The use of I2 statistic showcased significant heterogene- ity between the studies, as I2 was > 50% in all five groups. This heterogeneity is reflected in the forest plots of each group, with the heterogeneous distribution of the studies around the integrated error rate. Furthermore, Egger’s test indicated the absence of potential publication bias. The members of the disciplinary team manage the medi- cation delivery system and as a result, they become involved in medication errors of pediatric patients. A medication error is not the direct result of a sole member of the dis- ciplinary team’s misconduct, and the accusation of that person should not be pursued or recognized as a reward for reporting the error. The awareness of the existence of medication errors in clinical daily practice, as well as the interactive nature of the medication use process, with the participation of all members of the disciplinary team, leads to a better understanding of the errors. Consequently, the results of this meta-analysis offer useful information for healthcare professionals, as they provide the opportunity of understanding the nature and frequency of medication errors, and the ability to re-evaluate and improve the med- ication process. Furthermore, the existence of integrated error rates, related to medication errors in pediatric patients, can con- tribute to the understanding of the nature, frequency, and consequences of medication errors, as well as the necessity of the development of medication error reduction strate- gies, staff education, and clinical protocols and guidelines. Limitations The evaluation of the heterogeneity and the identification of its causes constitute parallel limitations of this meta- analysis. The selection of the studies solely published in English was a limitation, as well as the heterogeneity of the studies. The heterogeneity emanates from the variety of the stud- ies’ characteristics. Initially, the different error definition, as previously mentioned, complicated the studies’ grouping. Another reason was the different conditions under which each study took place. Emergency departments, for exam- ple, represented higher prescribing error rates,22,27,29,33 Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 11. 354 Koumpagioti D et al. while pediatric intensive care units and neonatal intensive care units presented high rates in all types of medication errors.11,16---18,25,31,32,34,36 There was also a variation in the studies’ design (cohort, randomized controlled trial, cross-sectional, retrospective, interventional), as well as in the age groups that took part in each study. Some of the age groups, such as neonates, may be more vulnerable to medication errors than preschool or school age children, due to their organic prematurity, the very small amounts of therapeutic drug doses, or their serious clinical condition. The denominators that each study used for the deter- mination of error frequency vary. Certain studies used handwritten orders or computerized orders as denomina- tors, while others were based on drug administrations. Computerized orders are more susceptible to the recog- nition of prescribing errors, in contrast to handwritten orders, where the identification of the error is at the dis- posal of the researcher or the professional who reported the error. Finally, there was a variety in the instruments that each study used for the data collection. Some stud- ies used chart reviews or observation, while others used error-reporting systems, thus minimizing the possibility of recognizing more errors, in contrast to using a combination of those instruments.6 In conclusion, medication errors in pediatric patients constitute a daily phenomenon in hospitals. Through this meta-analysis, it has been ascertained that the stages of prescription and administration were more prone to errors, as they demonstrated higher rates than the stage of dispens- ing. The stage of dispensing had the lowest error rates, with the pharmacist responsible for medication dispensing in the majority of the studies. The results of this meta-analysis highlight the neces- sity to improve the way that both clinicians and nurses are managing the medication process during the pediatric care delivering. Furthermore, the communication between the members of the multidisciplinary team regarding medica- tion errors in children should be focused on adoption of common definitions for medication errors and their cate- gories, staff education in recognizing medication errors, and implementation of error reporting in daily clinical practice. The establishment of medication error reduction strate- gies should constitute a goal for all healthcare institutions and a stimulus for the improvement of the pediatric care delivery. Conflicts of interest The authors declare no conflicts of interest. References 1. The Joint Commission. Sentinel event alert: preventing pedi- atric medication errors. Issue 39, April 11, 2008. [cited 1 Aug 2011]. Available from: http://www.jointcommission.org/ SentinelEvents/SentinelEventAlert/sea 39.htm 2. Ghaleb MA, Barber N, Franklin BD, Yeung VW, Khaki ZF, Wong IC. Systematic review of medication errors in pediatric patients. Ann Pharmacother. 2006;40:1766---76. 3. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Fed- erico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114---20. 4. Cowley E, Williams R, Cousins D. Medication errors in chil- dren: a descriptive summary of medication error reports submitted to the United States pharmacopeia. Curr Ther Res. 2001;62:627---40. 5. Fortescue EB, Kaushal R, Landrigan CP, McKenna KJ, Clapp MD, Federico F, et al. Prioritizing strategies for preventing medi- cation errors and adverse drug events in pediatric inpatients. Pediatrics. 2003;111:722---9. 6. Miller MR, Robinson KA, Lubomski LH, Rinke ML, Pronovost PJ. Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations. Qual Saf Health Care. 2007;16:116---26. 7. National Coordinating Council for Medication Error Repor- ting and Prevention. Statement from NCC MERP: use of medication error rates to compare health care organiza- tions is of no value. [cited 1 Oct 2011]. Available from: http://www.nccmerp.org/council/council2002-06-11.html 8. Gonzales K. Medication administration errors and the pediatric population: a systematic search of the literature. J Pediatr Nurs. 2010;25:555---65. 9. United States Pharmacopeia. Medication use process. Rockville, MD: United States Pharmacopeia; 2004. [cited 1 Aug 2011]. Available from: http://www.usp.org/pdf/EN/ patientSafety/medicationUseProcess.pdf 10. Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, et al. Outpatient prescribing errors and the impact of computerized prescribing. J Gen Intern Med. 2005;20:837---41. 11. Potts AL, Barr FE, Gregory DF, Wright L, Patel NR. Computer- ized physician order entry and medication errors in a pediatric critical care unit. Pediatrics. 2004;113:59---63. 12. Williams DJ. Medication errors. J R Coll Physicians Edinb. 2007;37:343---6. 13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al., Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008---12. 14. Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in COPD: a systematic review. Chest. 2009;136:734---43. 15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of ran- domized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1---12. 16. Prot S, Fontan JE, Alberti C, Bourdon O, Farnoux C, Macher MA, et al. Drug administration errors and their determinants in pediatric in-patients. Int J Qual Health Care. 2005;17: 381---9. 17. Frey B, Buettiker V, Hug MI, Waldvogel K, Gessler P, Ghelfi D, et al. Does critical incident reporting contribute to medication error prevention? Eur J Pediatr. 2002;161:594---9. 18. Wang JK, Herzog NS, Kaushal R, Park C, Mochizuki C, Weingarten SR. Prevention of pediatric medication errors by hospital phar- macists and the potential benefit of computerized physician order entry. Pediatrics. 2007;119:e77---85. 19. Chua SS, Chua HM, Omar A. Drug administration errors in pae- diatric wards: a direct observation approach. Eur J Pediatr. 2010;169:603---11. 20. Ghaleb MA, Barber N, Franklin BD, Wong IC. The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child. 2010;95:113---8. 21. Fontan JE, Maneglier V, Nguyen VX, Loirat C, Brion F. Medica- tion errors in hospitals: computerized unit dose drug dispensing system versus ward stock distribution system. Pharm World Sci. 2003;25:112---7. Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
  • 12. Evaluation of the medication process in pediatric patients 355 22. Kozer E, Scolnik D, Macpherson A, Keays T, Shi K, Luk T, et al. Variables associated with medication errors in pediatric emer- gency medicine. Pediatrics. 2002;110:737---42. 23. King WJ, Paice N, Rangrej J, Forestell GJ, Swartz R. The effect of computerized physician order entry on medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003;112:506---9. 24. Sard BE, Walsh KE, Doros G, Hannon M, Moschetti W, Bauchner H. Retrospective evaluation of a computerized physician order entry adaptation to prevent prescribing errors in a pediatric emergency department. Pediatrics. 2008;122:782---7. 25. Sangtawesin V, Kanjanapattanakul W, Srisan P, Nawasiri W, Ingchareonsunthorn P. Medication errors at Queen Sirikit National Institute of Child Health. J Med Assoc Thai. 2003;86:S570---5. 26. Taylor BL, Selbst SM, Shah AE. Prescription writing errors in the pediatric emergency department. Pediatr Emerg Care. 2005;21:822---7. 27. Jain S, Basu S, Parmar VR. Medication errors in neonates admit- ted in intensive care unit and emergency department. Indian J Med Sci. 2009;63:145---51. 28. Kadmon G, Bron-Harlev E, Nahum E, Schiller O, Haski G, Shonfeld T. Computerized order entry with limited decision support to prevent prescription errors in a PICU. Pediatrics. 2009;124:935---40. 29. Larose G, Bailey B, Lebel D. Quality of orders for medication in the resuscitation room of a pediatric emergency department. Pediatr Emerg Care. 2008;24:609---14. 30. Rinke ML, Moon M, Clark JS, Mudd S, Miller MR. Prescribing errors in a pediatric emergency department. Pediatr Emerg Care. 2008;24:1---8. 31. Cimino MA, Kirschbaum MS, Brodsky L, Shaha SH. Child Health Accountability Initiative. Assessing medication prescrib- ing errors in pediatric intensive care units. Pediatr Crit Care Med. 2004;5:124---32. 32. Campino A, Lopez-Herrera MC, Lopez-de-Heredia I, Valls-i- Soler A. Educational strategy to reduce medication errors in a neonatal intensive care unit. Acta Paediatr. 2009;98: 782---5. 33. Porter SC, Kaushal R, Forbes PW, Goldmann D, Kalish LA. Impact of a patient-centered technology on medication errors during pediatric emergency care. Ambul Pediatr. 2008;8: 329---35. 34. Otero P, Leyton A, Mariani G, Ceriani Cernadas JM, Patient Safety Committee. Medication errors in pediatric inpatients: prevalence and results of a prevention program. Pediatrics. 2008;122:e737---43. 35. Kozer E, Scolnik D, MacPherson A, Rauchwerger D, Koren G. Using a preprinted order sheet to reduce prescription errors in a pediatric emergency department: a randomized, controlled trial. Pediatrics. 2005;116:1299---302. 36. Raja Lope RJ, Boo NY, Rohana J, Cheah FC. A quality assur- ance study on the administration of medication by nurses in a neonatal intensive care unit. Singapore Med J. 2009;50: 68---72. Document downloaded from http://jped.elsevier.es, day 22/07/2014. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.